Drugnet Ireland. by unknown
In this issue 
Social inclusion 
and drugs policy
See pages 6-9
04 Misuse of Drugs Act 
09 NPS legislation in UK
12 Infectious diseases in 
prison
20 Addiction nurses 
conference
22 LGBTI people and 
mental health
Drugnet Ireland is  
produced in collaboration 
with the HRB National  
Drugs Library. To have 
Drugnet Ireland delivered  
to your desktop, sign up at  
www.drugsandalcohol.ie 
Research. Evidence. Action.
Issue 59 | Autumn 2016
IRELAND
Alcohol can be described as a psychoactive 
substance with dependence-producing 
properties and is responsible for a considerable 
burden of death, disease and injury in Ireland. 
A recent report by the Health Research Board provides an 
overview of the current situation in Ireland regarding alcohol 
consumption and harm and trends over time as well as outlining 
the available policy responses to alcohol-related harm.1 The data in 
this report were based predominantly on published Irish literature 
and existing information systems.
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In brief
Recent work by epidemiologists examining 
the social determinants of health and 
well-being has demonstrated the adverse 
consequences of inequality, including 
increased levels of incarceration, crime and 
illicit drug use. 
This research concludes that it is not the overall level 
of wealth of a society that determines the prevalence 
of poor health and social problems but the extent of 
the difference between the richest and the least well 
off. While this link is not made explicit in Irish drugs 
policy, the link between socioeconomic disadvantage, 
marginalisation and exclusion, and drug use has been 
recognised in the formulation of policy in this area for 
nearly 20 years. This is reflected in the framing of the 
2001-2008 and 2009-2016 National Drug Strategies in 
the context of the broader social inclusion agenda. The 
link between drug use and social deprivation underpins 
the rationale behind the location of local drugs task 
forces, and the relationship between illicit drug use and 
social exclusion and inequality is a key consideration in 
the strategies of the regional task forces set up nearly a 
decade later. 
The evolution of social inclusion policy and the 
positioning of illicit drug use within it are examined 
in detail in this issue of Drugnet Ireland. Economic 
deprivation is not the sole determinant of 
marginalisation. Membership of an ethnic minority, sexual 
orientation or disability often present economic and 
social challenges - risk factors which may increase the 
likelihood of drug use. While well-established monitoring 
systems provide valuable data on population drug use, 
examining the link between social marginalisation and 
drug use requires more refined analysis. Research using 
National Drug Treatment Reporting System (NDTRS) data 
has highlighted aspects of drug use among members 
of the Traveller community. Recent developments in 
the NDTRS also provide valuable information on drug 
prevalence in prisons and the treatment needs of 
members of the lesbian, gay, bisexual and transgender 
(LGBT) community. Homelessness is a particularly 
important risk factor associated with a wide range of 
health problems, including drug use, and in this issue we 
look at a recent study of users of a dedicated primary 
care service for homeless people in Dublin.
Social and economic policies designed to reduce 
inequality will impact on overall drug prevalence. 
Developing services which can respond effectively to the 
particular needs of marginalised and vulnerable groups 
will need to be informed by robust evidence from studies 
focused specifically on these groups. 
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which accounted for 11.0% of all public healthcare expenditure 
that year. The majority of these costs (77.4%) were associated 
with discharges with partially attributable alcohol conditions. 
This excludes the cost of emergency cases, GP visits, 
psychiatric admissions and alcohol treatment services.
Alcohol-related mortality
Alcohol mortality data from the National Drug-Related Deaths 
Index (NDRDI) were analysed for 2008-2013. There were 6,479 
alcohol-related deaths between 2008 and 2013. In 2013, there 
were 1,055 deaths, which is an average of 88 deaths per month 
or three deaths per day. Overall, 73.2% were aged under 65 
years, which may be described as of working age. From 2008 
to 2013, medical causes accounted for 4,462 (68.9%) of 
alcohol-related deaths, poisonings accounted for 1,045 (16.1%), 
and traumatic causes accounted for 972 (15.0%) of alcohol-
related deaths, with a similar pattern for males and females.
Alcohol and the workplace
In Ireland, alcohol is associated with harm in the workplace. 
According to the National Alcohol Diary Survey 2013,2 
unemployed people were twice as likely as employed people 
to have a positive DSM-IV score for dependence. Among those 
who were unemployed, 1.4% reported that they had lost 
their job as a result of their alcohol consumption; when the 
experience among this representative sample is applied to the 
unemployed population, it is possible that 5,315 people on 
the Live Register in 2013 had lost their job due to alcohol use. 
The survey also indicated that 4.2% of employed respondents 
reported that they had missed days from work due to their 
alcohol use in the 12 months prior to the survey. On average, 
each of these respondents missed 3.3 days. Based on 2013 
employment figures, we can extrapolate that of the 1,869,900 
persons in employment, 78,536 missed work in the previous 
year due to alcohol. If we assume that the average daily cost 
is €159.32 per person, this suggests that the direct cost of 
alcohol-related absenteeism was €41,290,805 in 2013. This 
estimate does not include the costs associated with reduced 
productivity at work or the cost of alcohol-related injury at 
work. Of those who reported missing work due to alcohol, 
82.6% engaged in monthly binge drinking and 40.8% scored 
positive for alcohol dependence. 
Conclusion
The data presented in this overview indicate that harmful 
drinking has become the norm in Ireland. The health of 
Irish people would improve if we reduce overall alcohol 
consumption and address risky drinking patterns. There is 
a comprehensive body of international evidence regarding 
the most effective policies to reduce alcohol-related harm. 
These include making alcohol more expensive, restricting its 
availability and reducing its promotion. The new Public Health 
Alcohol Bill contains these evidence-based measures and 
needs to be implemented without delay. 
Deirdre Mongan
1  Mongan D and Long J (2016) Overview of alcohol consumption, 
alcohol-related harm and alcohol policy in Ireland. Dublin: 
Health Research Board. http://www.drugsandalcohol.ie/25697/
2 Long J and Mongan D (2014) Alcohol consumption in Ireland 
2013: analysis of a national alcohol diary survey. Dublin: Health 
Research Board. http://www.drugsandalcohol.ie/22138
Alcohol consumption in Ireland
Ireland has a high level of alcohol consumption and many 
Irish people engage in harmful drinking patterns. In 2014, 
Irish drinkers consumed 11 litres of pure alcohol each. This is 
equal to 29 litres of vodka, 116 bottles of wine or 445 pints of 
beer. As 20.6% of the adult population abstain from alcohol 
completely, those who drink alcohol consume even greater 
quantities. Survey data from 2013 indicate that drinkers in 
Ireland consume alcohol in an unhealthy pattern: 37.3% of 
drinkers engaged in monthly, risky single-occasion drinking 
(RSOD), more commonly known as binge drinking, in the 
previous year; 54.3% of drinkers had a positive score on the 
AUDIT-C screening tool; 6.9% scored positive for dependence, 
which indicates that there were somewhere between 149,300 
and 203,897 dependent drinkers in Ireland in 2013. At least 
three-quarters of the alcohol consumed was done so as part 
of a binge-drinking session. 
There has been a shift from consuming alcohol in on-trade 
premises to consuming alcohol bought from the off-trade, 
which is reflected in Irish licence data. Between 1998 and 
2013, the number of pub licences in Ireland decreased by 19.1% 
(from 10,395 to 8,402). During the same period the combined 
number of wine and spirits off-licences increased by 377% 
(from 1,072 to 5,116). In 2013, there was one licence per 197 
adults aged 18 years and over.
Alcohol-related harm in Ireland
Alcohol-related morbidity
Alcohol-related morbidity was analysed using data from 
the Hospital In-Patient Enquiry (HIPE) scheme. The analysis 
included all alcohol-related discharges that were either wholly 
attributable (alcohol is a necessary cause for these conditions 
to manifest) or partially attributable (alcohol must be a 
component cause). The number of wholly attributable alcohol-
related discharges increased from 9,420 in 1995 to 17,120 in 
2013, an increase of 82%, with males accounting for 72.4% of 
discharges and females accounting for 27.6% of discharges. 
In 2013, alcohol-related discharges accounted for 160,211 bed 
days or 3.6% of all bed days that year, compared with 56,264 
bed days or 1.7% of the total number of bed days in 1995. The 
mean length of stay increased, from 6.0 days in 1995 to 10.1 
days in 2013, which suggests that patients with alcohol-related 
diagnoses are becoming more complex in terms of their illness. 
Alcoholic liver disease was the most common chronic alcohol 
disease, accounting for approximately four-fifths of all alcohol-
related chronic diseases in 2013. The rate of these discharges 
increased from 28.3 per 100,000 adults aged 15 years and 
over in 1995 to 87.7 in 2013, an increase of 210%. The most 
pronounced increase was among 15-34-year-olds, albeit from 
a low base.
The number of discharges with a partially attributable alcohol 
condition increased between 2007 and 2011 by 8.8%, from 
52,491 to 57,110. The estimated cost to the health system  
in 2012 of dealing with inpatients with either a wholly or 
partially alcohol-attributable condition was €1.5 billion,  
Overview of alcohol 
consumption and alcohol-
related harm continued
4
dr
ug
ne
t I
R
EL
AN
D
   
   
Is
su
e 
59
 |  
Au
tu
m
n 
20
16 Revocation of ministerial regulations and orders
Section 3 of the Act amends section 5 of the Misuse of Drugs 
Act and allows the Minister for Health to revoke ministerial 
regulations and orders confirmed by the Misuse of Drugs 
(Amendment) Act 2015.3 The aim of this amendment is to 
enable the Minister to create new regulations or orders as 
necessary to control new substances under the Act.
Technical amendments
To allow the commencement of a section in the Irish 
Medicines Board (Miscellaneous Provisions) Act 2006,8 
responsibility for issuing licences under the Misuse of Drugs 
Act 1977 will be reassigned from the Minister for Health to 
the Health Products Regulatory Authority. Finally, following 
alterations to the Nurses and Midwives Act 2011,9 the 
reference to nurses and midwives in the Misuse of Drugs Act 
1977 will be brought up to date.
Commencement
The Act involves a two-step process. Controlling substances 
are dealt with in the first stage of the Act. This will be 
followed by the drafting of regulations that will enable 
legitimate users (e.g. patients with prescriptions) access 
to controlled substances. The Act will commence when 
appropriate regulations are in place.
Extensive debate
As the Act progressed through the Dáil and Seanad, extensive 
debate occurred between deputies. Predominantly, the Act 
is welcomed by many. In light of recent events in Ireland, 
Deputy John Lahart purported that it was clear that there 
was a necessity to reinforce the legislation around drug 
misuse (p. 597).4 Deputy Jack Chambers argued that allowing 
law enforcement agencies to pursue gangs that control the 
supply and sale of drugs was an essential route to targeting 
drug-related crime in Ireland (p. 595).4 However, numerous 
concerns were raised that the Act was not going to address 
the root causes of the problem. For example:
• Deputy Jonathan O’Brien purported that the Act was being 
rushed at the request of An Garda Síochána and raised 
concerns that neither drug service providers nor medical 
practitioners were consulted. He further argued that the 
Act ‘will criminalise vulnerable drug addicts’ and purported 
that a model of decriminalisation of drugs for personal 
use was necessary. This, he argued, should be centred 
on evidence, based on international best practice, for 
example, the Portuguese model. He cautioned that thus far 
the introduction of this kind of Act went against ministerial 
talk about availing of evidence-based practice, which 
seemed to be ignored in this instance (pp. 600-04).4
• Deputy Louise O’Reilly viewed the Act as solving only half 
the problem, namely drug crime, and did not address 
any measures to provide support to help addicts, nor 
did it address the socioeconomic impacts of addiction 
nor the issue of drugs overall. Deputy O’Reilly argued 
that although this legislation would alter drug-related 
antisocial behaviour, and increase Garda presence and 
capability, it was not targeting the root causes of the 
problem (pp. 604-06).4
• Deputy Maurice Quinlivan argued that ‘criminalising 
young people who, more often than not, are already 
disadvantaged is a lazy and bankrupt response of what is 
an exceptionally serious issue …. the legislation will not 
work as it offers nothing to address the root causes of 
POLICY AND LEGISLATION 
Misuse of Drugs 
(Amendment)  
Act 2016
Following increased drug-related violence and the 
emergence of new psychoactive substances to the Irish 
drug market, it became necessary to expedite a shortened 
version of the Misuse of Drugs (Amendment) Act 2016,1 which 
was enacted on 27 July 2016. The aim of the Act is to amend 
schedules from the Misuse of Drugs Acts 1977-2015.2 
The Misuse of Drugs Acts 1977-2015 is the main legislation 
that aims to protect society from the impact of drugs 
in Ireland. Protection is provided by firstly controlling 
access to substances that can be harmful if abused, e.g. 
benzodiazepines and heroin, via ministerial regulations and 
orders. This ensures that controlled drugs are used safely. 
Secondly, protection is provided by setting up a system that 
controls substances that are viewed as unsafe or destructive 
when not used for therapeutic reasons. Due to the transient 
and ever-changing nature of the drugs and the drug market, 
this Act is constantly monitored and updated. 
Provisions of the new Act
The main provisions of the 2016 Act include the addition 
of new substances, revocation of regulations and orders 
confirmed in the Misuse of Drugs (Amendment) Act 2015,3 
and some technical amendments.
Addition of new substances
A number of new substances are to be added to the existing 
list of controlled substances:
• Zopiclone
• Zaleplon
• Phenazepam
• Lisdexamfetamine
• Clockwork Orange
• MT-45
• 25B-NBOMe 
• 25C-NBOMe 
• 4,4’-DMAR 
• MDMB-CHMICA 
The inclusions will allow law enforcement authorities to 
deal more effectively with the illegal trafficking in Ireland, 
for example, on-street dealing of prescription medication, 
some of which are not controlled by current legislation.4 
In addition, it will allow Ireland to fulfil its obligations in 
accordance with EU directives, such as EU Council Decision 
2005/387/JHA5 - which demands information exchange, risk 
assessment, and control of new psychoactive substances − 
the United Nations Single Convention on Narcotic Drugs 19616 
and Convention on Psychotropic Substances 1971.7 
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this problem, which are disadvantage, marginalisation and 
the political indifference of the middle classes’ (p. 53).10 
• Another issue raised was the lack of resources and 
funding.
This is the first step of a series of approaches that are being 
taken to target the drug problem in Ireland. A further Misuse of 
Drugs (Amendment) Bill is due to be presented in the autumn 
term, which aims to establish supervised injection rooms.
Ciara H Guiney
1  Misuse of Drugs (Amendment) Act 2016 as initiated. Available 
online at http://www.oireachtas.ie/documents/bills28/
acts/2016/A0916.pdf 
2  Misuse of Drugs Act 1977. Available online at http://www.
irishstatutebook.ie/eli/1977/act/12/enacted/en/html 
3  Misuse of Drugs (Amendment) Act 2015. Available online at 
http://www.irishstatutebook.ie/eli/2015/act/6/enacted/en/pdf 
4  (2016, 6 July). Dáil Éireann debate. Misuse of Drugs 
(Amendment) Bill 2016: second stage, vol. 916, no. 3.  
http://www.drugsandalcohol.ie/25774/ 
5  EU Council Decision 2005/387/JHA. Available 
online at http://www.emcdda.europa.eu/
topics/law/drug-law-texts?pluginMethod=eldd.
showlegaltextdetail&id=3301&lang=en&T=2 
6  United Nations Single Convention on Narcotic Drugs 
1961. Available online at https://www.unodc.org/pdf/
convention_1961_en.pdf 
7  United Nations Convention on Psychotropic Substances 
1971. Available online at https://www.unodc.org/pdf/
convention_1971_en.pdf 
8  Irish Medicines Board (Miscellaneous Provisions) Act 2006. 
Available online at http://www.irishstatutebook.ie/eli/2006/
act/3/enacted/en/html 
9  Nurses and Midwives Act 2011. Available online at http://www.
irishstatutebook.ie/eli/2011/act/41/enacted/en/print
10 (2016, 7 July). Dáil Éireann debate. Misuse of Drugs 
(Amendment) Bill 2016: second stage (resumed), vol. 917, no. 1. 
http://www.drugsandalcohol.ie/25797/ 
Misuse of Drugs (Amendment) 
Act 2016 continued
to austerity. Some people in the Clondalkin area had been 
subjected to a range of ‘policy induced harms’ that have put 
them at a higher risk of experiencing drug-related harms. The 
authors argued that the current media and political debate 
tended to pathologise people, groups and communities that 
experience poverty as an outcome of individual or family 
dysfunction. Furthermore, that ‘little attention was paid to 
the role government decisions and policies play in shaping 
negative life outcomes for people’ (p. 6).
Drug trends
Drug use within the area was found to be characterised 
by polydrug use. The ‘polydrug activity’ tended to involve 
cannabis and ‘tablets’ (e.g. benzodiazepines and the ‘Z drugs’) 
combined with alcohol. Cocaine, new psychoactive substances 
(e.g. mephedrone) and various ‘ecstasy type’ substances 
were reported to be widely used in ‘recreational settings’. 
Heroin and crack cocaine were perceived to be used by a 
small proportion of habitual users in high-risk conditions, and 
rarely by young people. While the drugs used varied somewhat 
depending on what was available, there was a general 
consensus that drugs were widely available in the area.
Risk groups for drug-related harms
Four groups living in the area were found to be at particularly 
high risk of experiencing drug-related harm: 
• The in-treatment population whose needs were not 
being met by the range of services available. 
• Family members of those involved in problematic drug 
use, including children living with parental drug use. 
• Members of the Traveller community. 
• Young people in the area who, given the multiple and 
interconnected deprivations they experienced, were at 
risk of becoming users themselves. Furthermore, in the 
absence of viable employment opportunities they were 
at risk of becoming involved in the local drugs economy. 
The study found that this economy provided ‘one of 
the few employment and economic opportunities for 
Outcomes: drug 
harms, policy 
harms, poverty and 
inequality
On 28 April 2016, Clondalkin Drug and Alcohol Task Force 
(CDATF) held a conference on ‘Outcomes: drug harms, policy 
harms, poverty and inequality’, at which they launched their 
report of the same name.1 
The day brought together 120 delegates and stakeholders, 
including policy-makers, service providers, service users 
and other representatives from community, voluntary and 
statutory agencies. 
Key findings from the report
Research aims
Key findings from the report were presented by its lead author 
Dr Aileen O’Gorman of the University of the West of Scotland. 
The overall aim of the research was to provide an in-depth 
understanding of: patterns of drug use and drug-related 
harm in the Clondalkin area; and the needs of individuals, 
families and members of the broader community. It also set 
out to explore and identify the relationship between poverty, 
inequality and drug use, and review the effectiveness of the 
partnership approach to the coordination and delivery of 
community-based responses to drug use in the area. 
Poverty, inequality and policy-related harms
The report described the CDATF area as home to a 
disproportionate number of people experiencing poverty, with 
the situation having worsened as a result of political responses 
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poverty and inequalitycontinued
young people, leastways for a time, to access the status 
and goods that work provides’ (p. 7). The associated 
violence was an additional risk to which these young 
people were exposed.
Changing policy environment and partnership working
The authors found that CDATF operated in a very different 
policy environment when compared with that in which it had 
been established. They described a move towards a neo-liberal 
policy environment in which the centralisation of decision-
making had increasingly become the norm. This undermined 
the way in which the Drug and Alcohol Task Force (DATF) had 
worked traditionally and caused a shift from working in a 
community-based bottom-up approach to delivering on the 
National Drugs Strategy to a ‘hierarchical top-down approach’ 
(p. 8). They identified two ways in particular in which the 
community-based interagency and partnership approach had 
been undermined: first, there were fewer ‘spaces’ (p. 8) for 
communities and community-based services to input into 
decision-making; and, secondly, there were ‘extreme levels’ 
of monitoring, reporting requirements, and effectiveness and 
value-for-money evaluations. 
Conclusion
The authors argued that there was a need to review the impact 
of austerity and reform policies on drug-related harms and 
the ability of local services and the DATFs to respond to the 
increased levels of need in their areas. They called for a social 
inclusion pillar to be included in the National Drugs Strategy, 
due to commence in 2017, as well as the introduction of drug 
and poverty proofing for future public and social policies: 
Drug policy in Ireland has become more focused on 
addressing individual drug using behaviour as if these 
issues were context free. Little attention is paid in 
policy discourses to the underlying issues of poverty 
and inequality and even less consideration is given to 
the harmful outcomes of policy. (p. 8)
Other presentation themes
Presentations at the conference were also made by: 
• Professor Kathleen Lynch, UCD School of Social Policy, 
Social Work and Social Justice
• Professor Susan MacGregor, London School of Hygiene 
and Tropical Medicine
• Fr Peter McVerry of the Peter McVerry Trust
• Pearse Stafford, service user representative
A number of themes recurred throughout the presentations, 
including:
• Certain sections of society have been disproportionately 
affected by political austerity measures (in particular 
young people). This has contributed to a progressively 
unequal society and an environment in which people are 
increasingly socially excluded.
• Drug use does not occur in a vacuum and the social 
context in which people are living needs to be 
considered when discussing how best to tackle the issue 
of problematic drug use in an area. This is challenging in 
what was described as an increasingly ‘neo-liberal State’.
• In the absence of ‘legitimate’ employment opportunities 
in some areas, participating in the drugs economy was 
perceived to offer young people an opportunity to 
generate an income and attain standing in their community.
• There has been an increasing level of violence 
associated with the drug trade. This was affecting whole 
communities, not just drug users.
• There has been a tendency towards less and less 
meaningful community consultation and engagement in 
policy development and delivery. There were concerns 
that this would continue to be the case with the 
development of the new National Drugs Strategy.
Throughout the day the report was warmly welcomed by 
conference delegates; the findings of the report echoed the 
experiences of those working in other task force areas. In 
addition, the findings of the report and the conference were 
to be used to inform the following: CDATF’s forthcoming 
strategic plan; their submission to the new National Drugs 
Strategy; and the debate on poverty, inequality and drug-
related harm more broadly. The report was cited in Leaders’ 
Questions in the Dáil on 25 May 2016.2 
Lucy Dillon
1  O’Gorman A, Driscoll A, Moore K, Roantree D (2016)  
Outcomes: drug harms, policy harms, poverty and  
inequality. Dublin: Clondalkin Drug and Alcohol Task Force.  
http://www.drugsandalcohol.ie/25577/
2  Adams G (2016, 25 May). Dáil Éireann debate. Leaders’ 
questions, vol. 910, no. 2. http://www.drugsandalcohol.
ie/25560/
Programme for Government, which, while retaining the 
concept of social inclusion, brought two new terms to the 
fore in relation to social policy - fairness and equality.4
In 2016, as a new Programme for Government is published, 
and as the suite of social inclusion policy documents 
conceived during the Celtic Tiger reach their endpoints, 
it is timely to review the current status of Ireland’s social 
inclusion policy framework.
Leading up to 2016
In 2005, the National Economic and Social Council (NESC) 
published a report, The developmental welfare state, 
Where next for  
social inclusion?
In 2006-2007, Drugnet Ireland carried a series of articles 
reviewing how illicit drugs were addressed in the new social 
inclusion policy framework, i.e. the new Social Partnership 
Agreement 2006-2015,1 the National Development Plan 
2007-2013,2 and the National action plan for social inclusion 
2007-2016.3 In 2011, Drugnet carried an article on the new 
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emerging issues, with the number of high-level goals being 
expanded to include early childhood development, youth 
exclusion, access to the labour market, migrant integration, 
social housing and affordable energy.
The revised action plan describes how the context of social 
inclusion policy has altered. The 2007 action plan was 
‘designed to ensure that those experiencing poverty and 
social exclusion would share in the fruits of the economic 
development being achieved at that time’, but since 2008 
Ireland has experienced a ‘major economic recession 
complicated by banking and fiscal crises’. The Government’s 
response to combating poverty now concentrates on 
transforming the social protection system into one 
that focuses on maximising employability, by improving 
effectiveness and efficiency of social transfers by providing 
training, development and employment services along with 
income supports, and by strengthening active inclusion 
policies, which are described as follows:
Active inclusion means enabling every citizen, 
notably the most disadvantaged, to fully participate 
in society, including having a job. Active inclusion 
is intended to tackle various challenges including: 
poverty, social exclusion, in-work poverty, labour 
market segregation, long-term unemployment and 
gender inequalities. (p. 4)
Programme for Government 2016
The new Partnership Government’s programme for a 
‘fairer Ireland’ contains a chapter headed ‘Creating a 
Social Economy’, which is the model the Government 
will apply in order to deliver ‘a strong economy and a fair 
society’.12 Reflecting the shift already noted in the revised 
national action plan on social inclusion, the Programme for 
Government identifies four foundations of a social economy, 
including ‘a just and fair society and a more inclusive 
prosperity’. Four tasks will be undertaken to build this just 
and fair society and a more inclusive prosperity:  
• developing a new integrated framework for social 
inclusion, to tackle inequality and poverty;
• reducing poverty levels by improving the take-home 
pay of families on low-incomes;
• reducing poverty levels by supporting an increase in 
the minimum wage to €10.50 per hour over the next 
five years; and
• reinforcing labour market activation.
Just what an ‘integrated framework for social inclusion’ 
comprises is outlined in the Programme for Government:
Our Integrated Framework will outline measures 
to help eliminate any persisting discrimination 
on grounds of gender, age, family status, marital 
status, sexual orientation, race, disability, religion or 
membership of the Traveller Community. It will draw 
on existing as well as new strategies, in particular the 
(i) New National Women’s Strategy, (ii) New National 
Disability Inclusion Strategy, (iii) Comprehensive 
Employment Strategy for People with Disabilities, (iv) 
National Traveller and Roma Inclusion Strategy, and 
(v) New Action Plan for Educational Inclusion. (p. 39)13
which proposed a new streamlined and comprehensive 
approach to tackling poverty and social exclusion in Ireland.5 
Acknowledging that serious social deficits remained despite 
Ireland’s economic progress, the NESC report combined the 
economic and the social, suggesting that this would help 
to build consensus across the social partners, government 
and wider society. It proposed two innovations in the way of 
presenting social inclusion interventions:
1   Interventions should be organised according to a 
life cycle framework, comprising four categories: 
children, people of working age, older people, 
and people with disabilities. This arrangement 
both placed the individual at the centre of policy-
making and encouraged a more joined-up and 
multidisciplinary approach to policy-making. 
2   Greater recognition and weight should be given 
to (a) the role of services in providing protection 
against risks, and (b) activist measures, or 
innovative social policy initiatives, in meeting 
unmet needs and pre-empting problems, as 
opposed to focusing entirely on income transfers. 
Published in 2006, the 10-year Social Partnership Agreement 
Towards 2016 was the first policy framework to adopt the 
new life cycle approach.6 Drug-related initiatives were 
identified in the childhood and young working adult stages of 
the framework. 
In 2007, as well as setting a national poverty target of 
reducing the number experiencing consistent poverty to 
between 2% and 4% by 2012, with the aim of eliminating 
consistent poverty by 2016,7 the National action plan for 
social inclusion 2007-2016 (NAPinclusion) also adopted 
the life cycle framework, adding an extra category 
‘Communities’.8 
Within this Communities category, NAPinclusion itemised 
a series of community-based programmes (including 
the National Drugs Strategy) and a number of innovative 
measures in areas such as the arts, sport, and active 
citizenship, which were expected to have an impact  
on the illicit drugs issue. 
In June 2010, the European Council adopted Europe 2020:  
a strategy for smart, sustainable and inclusive growth, 
which aims to promote employment, improve living and 
working conditions, provide an appropriate level of social 
protection, and develop measures to combat exclusion.9 In 
2012, Ireland revised its national poverty target (now named 
‘national social target for poverty reduction’) - to reduce 
consistent poverty to 4% by 2016 (interim target) and 2% 
or less by 2020, from the 2010 baseline rate of 6.3% - and 
identified the contributions that Ireland would make to the 
Europe 2020 poverty target.10 
Updated national action plan for social 
inclusion 2015-2017
Following the 2012 revisions, a revised national action plan 
for social inclusion for 2015-2017 was published.11 Maintaining 
the life cycle approach, this revised action plan reflects new 
Where next for  
social inclusion? continued
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Social inclusion and 
drugs policy 
This article outlines how the concept of social inclusion  
has been incorporated into the national drugs policy 
framework over the past 20 years as well as issues to 
consider going forward. 
1996-2016
As long ago as 1996, the Ministerial Task Force on Measures to 
Reduce the Demand for Drugs recognised the link between 
problem drug use and socioeconomic disadvantage.1 The 
task force recommended the establishment of local drugs 
task forces in areas experiencing high levels of problem drug 
use, which coincided with areas experiencing social and 
economic disadvantage.
Ireland’s two subsequent seven-year national drugs 
strategies, published in 20012 and 2009,3 both set Ireland’s 
drug policy within the wider social inclusion policy context, 
to which a number of other national strategies, such as 
health,4 anti-poverty5 and education,6 had also been linked.
2001: The Group fully recognises that, 
notwithstanding the obvious benefits for 
communities affected by the drugs problem of 
having a specific drugs strategy, the best prospects 
for these communities, in the longer term, rest 
with a social inclusion strategy which delivers much 
improved living standards to areas of disadvantage 
throughout the country. (para. 6.1.9)
2009: The Group … notes that the Cabinet Committee 
on Social Inclusion, Children and Integration deals 
with a wide range of social inclusion policy areas, of 
which drugs is one issue. While the scope for routine 
debate on drugs is limited, therefore, the Group 
acknowledges that addressing the broader social 
inclusion agenda ensures that the drugs issue is taken 
into consideration, as it is an integral aspect of many 
of the social inclusion priorities. (para. 6.21)
2017 and after?
How the new National Drugs Strategy will address the links 
between social inclusion and illicit drugs policies remains to 
be seen. For example:
• How will social inclusion and illicit drug policy be handled 
at Cabinet level? 
• How will different government departments, state 
agencies, drugs task forces, and community and 
voluntary organisations be expected to address social 
inclusion and drug-related issues and with each other? 
• How will the concepts of active inclusion, life cycle 
framework and integrated social inclusion framework, 
all mentioned in Ireland’s current social inclusion policy 
framework, be applied in the drugs policy context?
Two articles in earlier issues of Drugnet Ireland on the links 
between social inclusion and drug policy have highlighted the 
importance of integrated responses.
Inequality and illicit drug use4
In their study of the links between health, social problems 
and inequality, Wilkinson and Pickett5 argue that policy-
makers should integrate health and social problems as 
elements of a single policy problem - inequality - rather  
than approach them as separate issues:
In the following article, the relationship between social 
inclusion policy and Ireland’s national drugs strategies over 
the past 20 years is explored. 
Brigid Pike
1   Pike B (2006) New social partnership agreement  
addresses drugs and alcohol. Drugnet Ireland, 19: 7.  
http://www.drugsandalcohol.ie/11277/ 
2   Pike B (2007) National Development Plan and the drugs issue. 
Drugnet Ireland, 21: 23-25. http://www.drugsandalcohol.
ie/11342/ 
3   Pike B (2007) Where do illicit drugs fit in the new social 
inclusion policy framework?’ Drugnet Ireland, 23: 5.  
http://www.drugsandalcohol.ie/11409/ 
4   Pike B (2011) Inequality and illicit drug use. Drugnet Ireland,  
38: 8-10. http://www.drugsandalcohol.ie/15639/
5   National Economic and Social Council (2005) The 
developmental welfare state. Dublin: NESC. Retrieved 1 July 
2016 from http://www.nesc.ie/en/publications/publications/
nesc-reports/the-developmental-welfare-state/ 
6   Department of the Taoiseach (2006) Towards 2016: ten-year 
framework social partnership agreement 2006-2015. Dublin: 
Stationery Office. http://www.drugsandalcohol.ie/6320/ 
7  ‘Consistent poverty’ is the overlap of two component indicators: 
at-risk-of-poverty, which identifies individuals with household 
incomes below 60% of the median, and basic deprivation, which 
captures individuals lacking two or more of 11 basic necessities.
8 Office for Social Inclusion (2007) National action plan  
for social inclusion 2007-2016. Dublin: Stationery Office.  
http://www.drugsandalcohol.ie/13378/ 
9  For more information on Europe 2020, visit  
http://ec.europa.eu/europe2020/index_en.htm
10 Department of Social Protection (2012) National social 
target for poverty reduction: policy briefing on the review 
of the national poverty target. http://www.welfare.ie/en/
downloads/2012_nptbriefing.pdf
11  Department of Social Protection (2016) Updated national 
action plan for social inclusion 2015-2017. Dublin: Department 
of Social Protection. https://www.welfare.ie/en/downloads/
Updated%20National%20Action%20Plan%20For%20
Social%20Inclusion%202015-2017.pdf
12 Government of Ireland (2016) A programme for partnership 
government. Dublin: Department of the Taoiseach.  
http://www.drugsandalcohol.ie/25508/ 
13 At the time of going to press, only one of the five ‘new 
strategies’ had been published. Government of Ireland 
(2015) Comprehensive employment strategy for people with 
disabilities. Retrieved 1 July 2016 from http://www.justice.ie/
en/JELR/Comprehensive%20Employment%20Strategy%20
for%20People%20with%20Disabilities%20-%20FINAL.pdf/
Files/Comprehensive%20Employment%20Strategy%20for%20
People%20with%20Disabilities%20-%20FINAL.pdf
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Attempts to deal with health and social problems 
through the provision of specialized services 
have proved expensive and, at best, only partially 
effective.... Rather than reducing inequality itself, 
the initiatives aimed at tackling health and social 
problems are nearly always attempts to break the 
links between socio-economic disadvantage and 
the problems it creates. The unstated hope is that 
people - particularly the poor - can carry on in the 
same circumstances, but will somehow no longer 
succumb to mental illness, teenage pregnancy, 
educational failure, obesity or drugs. (pp. 238-9) 
Applying the life cycle approach to social 
inclusion policy6
In an article about the life cycle approach to social inclusion 
policy in Ireland, Whelan and Maître7 explain how the life 
cycle approach marks a shift in perceptions of the nature of 
risk. Traditionally, social policy interventions have focused 
on risks associated with unemployment, disability, and 
insufficient resources in childhood and old age, and have 
tended to redistribute resources across the life cycle, from 
working age groups to children and to older people. More 
recently, social policy interventions have begun to focus on 
risks faced by specific subgroups at particular stages in their 
lives, for example, risks associated with entering the labour 
market, remaining in the labour market, or managing care 
responsibilities. These ‘new’ risk perceptions have emerged 
in response to the greater variability and reduced stability in 
career and family patterns. 
In essence, the life cycle approach seeks to 
reconcile social and economic objectives, and to 
emphasise the ‘multidimensional’ and ‘dynamic’ 
aspects of the social inclusion process: risks of being 
socially excluded are linked across problem areas, 
and difficulties experienced in any specific life cycle 
stage may be a consequence of difficulties in an 
earlier stage or a precursor of later problems.6
The authors go on to comment that while the life cycle 
approach offers a set of lenses through which to focus 
on the issues, it does not offer a ready-made set of 
prescriptions: 
…a ‘general analytic framework that accounts for 
the dynamics and the links between events and 
the appropriate analytic tools’ is needed. To fully 
understand the nature of the dynamic inter-related 
risks requires the mapping of social exclusion 
patterns across the life cycle, and an understanding 
of the manner in which they combine with other 
socio-economic characteristics.6
Brigid Pike
1  Ministerial Task Force on Measures to Reduce the Demand 
for Drugs (1996) First report of the ministerial task force on 
measures to reduce the demand for drugs. Dublin: Stationery 
Office. http://www.drugsandalcohol.ie/5058/ 
2  Department of Tourism, Sport and Recreation (2001) Building 
on experience: national drugs strategy 2001-2008. Dublin: 
Stationery Office. http://www.drugsandalcohol.ie/5187/ 
3  Department of Community, Rural and Gaeltacht  
Affairs (2009) National drugs strategy (interim) 2009–2016.  
Dublin: Department of Community, Rural and Gaeltacht Affairs. 
http://www.drugsandalcohol.ie/12388/ 
4  Pike B (2011) Inequality and illicit drug use. Drugnet Ireland,  
38: 8-10. http://www.drugsandalcohol.ie/15639/
5  Wilkinson R and Pickett K (2010) The spirit level: why equality 
is better for everyone. Published with revisions and a new 
postscript. London: Penguin Books. 
6  Pike B (2008) Applying the life cycle approach to social inclusion 
policy. Drugnet Ireland, 28: 19-20. http://www.drugsandalcohol.
ie/12148/ 
7  Whelan CT and Maître B (2008) ‘New’ and ‘old’ social risks: life 
cycle and social class perspectives on social exclusion in Ireland. 
Economic and Social Review, 39(2): 131-156.
Social inclusion and  
drugs policy continued
New psychoactive 
substances: 
legislative changes  
in the UK 
Psychoactive Substances Act 2016
The Psychoactive Substances Act 2016 came into force in the 
UK on 26 May 2016. In the Act, a ‘psychoactive substance’ 
is defined as one that ‘produces a psychoactive effect in a 
person if, by stimulating or depressing the person’s central 
nervous system, it affects the person’s mental functioning 
or emotional state; and references to a substance’s 
psychoactive effects are to be read accordingly’.1 The Act 
differs from the established approach to drug control under 
the UK’s Misuse of Drugs Act 1971 in that it covers substances 
by virtue of their psychoactive properties, rather than the 
identity of the drug or its chemical structure.2
Critics of the Act argue that this focus on the psychoactive 
properties of the substance is too broad - it means that 
technically the authorities could decide that any substance 
which changes a person’s mood could be included, 
irrespective of any evidence of the substance being harmful. 
In an effort to address this, the guidance accompanying 
the Act2 states that the effects of the substance are to 
be ‘as measured by the production of a pharmacological 
response on the central nervous system or which produces 
a response in in-vitro tests qualitatively identical3 to 
substances controlled under the Misuse of Drugs Act 1971’ (p. 
3).2 However, the guidance also notes that the Act captures 
all psychoactive substances that are not controlled by the 
Misuse of Drugs Act or are otherwise exempt. Exempted 
substances include controlled drugs (within the meaning 
of the UK’s Misuse of Drugs Act 1971), medicinal products, 
alcohol, tobacco products, caffeine, and food.1
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NPS come of age: a UK overview
To coincide with the introduction of the new Act, DrugWise 
published a report on novel psychoactive substances (NPS) 
- also known as new psychoactive substances. NPS come of 
age: a UK overview4 by Harry Shapiro provides a description 
of NPS from a range of angles, including the evolution of NPS 
in the UK; their use; how treatment services are dealing with 
the needs of their users; and the development of the new 
legislation. He compared the picture of NPS use in the UK 
in 2016 as ‘not dissimilar’ to that which appeared with the 
emergence of crack cocaine in the UK: ‘much sensational 
media reporting and dire predictions for the future, but 
ultimately finding a level in the drug scene with regular use 
primarily concentrated among those with existing serious 
drug problems and other vulnerable groups’ (p. 3).
The Internet and the lack of regulation of the substances 
involved were identified as enabling NPS to take their place in 
the global and UK drug markets. Their arrival was described 
as a ‘game-changer’ in terms of the Internet becoming a 
new route for wholesale and retail supply, distribution, and 
information exchange on drugs’ effects between users. 
In terms of the range of NPS, while Shapiro accepted that 
there can be ‘bewilderment’ among drugs workers at the 
ongoing appearance of ‘new’ substances, the difference 
between them was not always that significant. He described 
five groupings, and argued that many of the new compounds 
were simply variants of the first grouping: 
• Synthetic cannabinoids 
• Stimulant-type drugs (including mephedrone)
• Hallucinogenic-type drugs
• Opiate-type drugs
• Tranquiliser-type drugs
NPS users
NPS use has increased in the UK since 2006. However, 
identifying patterns and prevalence of their use in official 
datasets was found by Shapiro to be ‘patchy’. Among 
the reasons given for this was that the user groups most 
affected (e.g. students in student accommodation, adult 
prisoners, young offenders and the homeless) were unlikely 
to be identified in the UK’s routine official surveys that 
provide prevalence data. Based on his overall assessment 
of the evidence available, Shapiro generalised that NPS use 
is ‘most problematic in communities experiencing higher 
levels of poverty and deprivation and, where young people 
are involved, among those who in years gone past would 
have been involved in solvent use and heroin smoking’ 
(p. 12). He drew particular attention to the reported high 
levels of synthetic cannabinoid receptor agonists (SCRAs) 
use among prisoners in the UK. In particular, he noted the 
associated increases in levels of violence between prisoners 
and against staff, debt, intimidation, self-harm and ‘general 
psychotic behaviour’. The legal status of the substances and 
the fact that they could not be identified by the mandatory 
drug testing process in prisons had both contributed to the 
worsening situation.
Health impacts 
Shapiro found a growing body of international evidence to 
demonstrate the potential acute and chronic health harms 
associated with the use of NPS. He noted in particular the 
‘devastating effects’ of injecting mephedrone. While NPS 
were implicated in 62 fatalities in the UK in 2014, only seven 
deaths were as a direct result of taking an NPS in isolation. In 
most cases, ‘traditional’ drugs (e.g. heroin and methadone) 
were also implicated.
Meeting users’ needs
Relatively few people were coming forward to treatment 
services citing an NPS as their primary drug problem. Drug 
workers saw more use out in the community with clients who 
were not accessing treatment, for example, homeless and 
rough sleepers. However, those working in the community 
with young people reported problems with a range of NPS, 
especially mephedrone and synthetic cannabinoids. Shapiro 
emphasised the need for drug workers to ‘deal with the 
problem in front of you’, as the ‘whole intention’ of NPS 
was to mimic the effects of controlled drugs; in theory the 
symptoms service users present with should be similar to 
those already seen. He therefore recommended the clinical 
guidance published by Project Neptune.5
Legislation
Legislating for NPS is described as having provoked some 
of the most heated debate about UK drug law since 
cannabis was reclassified from Class B to Class C in 2004. 
The report described the legislative process gone through 
which culminated in the ‘blanket ban’ encapsulated in the 
Psychoactive Substances Act 2016. Shapiro described it as 
having met a ‘storm of criticism’ in the media and from drug 
law reform campaigners, commentators and academics. 
In particular, it was criticised for having turned the Misuse 
of Drugs Act ‘on its head’ by effectively saying that any 
substance that was psychoactive was harmful. It was also 
criticised for having removed the notion of relative harms, 
and there was scepticism about the legal robustness of any 
attempt to define ‘psychoactivity’. 
Lucy Dillon
1  Psychoactive Substances Act 2016 (UK). Available online 
at http://www.legislation.gov.uk/ukpga/2016/2/pdfs/
ukpga_20160002_en.pdf
2  Psychoactive Substances Act 2016: forensic strategy.  
Home Office Circulars 2016. London: Home Office.  
https://www.gov.uk/government/publications/circular-
0042016-psychoactive-substances-act-2016
3  ‘Qualitatively identical to’ means that the substance interacts 
with the same target as a known psychoactive drug controlled 
under the Misuse of Drugs Act 1971.
4  Shapiro H (2016) NPS come of age: a UK overview. London: 
DrugWise. http://www.drugsandalcohol.ie/25551/
5  Abdulrahim D and Bowden-Jones O, on behalf of the NEPTUNE 
Expert Group (2015) Guidance on the clinical management of 
acute and chronic harms of club drugs and novel psychoactive 
substances. London: Novel Psychoactive Treatment UK Network 
(NEPTUNE). http://neptune-clinical-guidance.co.uk/wp-
content/uploads/2015/03/NEPTUNE-Guidance-March-2015.pdf
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• The survey was designed to answer comparison questions 
that are not dependent on probability samples. 
• As the data was less than six months old, the findings can 
help identify emerging drug trends before they enter into 
the general population.
Key findings
 
Among the key findings were:
• 9.3% of respondents reported ever buying drugs off the 
‘dark net’; this represents an increase on previous years. 
MDMA, cannabis, new or novel substances and LSD were 
the drugs most commonly bought.
• Synthetic cannabinoids (SCs) were more likely to lead to 
emergency medical treatment than any other drug. One in 
eight of those using weekly or more often reported seeking 
emergency medical treatment. The overall risk of seeking 
emergency medical treatment when using SCs was found 
to be 30 times greater than when using ‘natural cannabis’.
• In terms of acute harms caused by alcohol, at 2.2% each, 
Ireland and Norway came in joint second to Scotland, 
where 2.4% of drinkers reported seeking emergency 
medical treatment following drinking alcohol.
• Globally, Ireland had the second highest proportion of 
people who would like to drink less alcohol (43.4%).
• While globally the mean price for high potency herbal 
cannabis was €12.48, in Ireland it was €23.
Lucy Dillon 
1  Global Drug Survey (GDS) (2016). For more information, 
visit https://www.globaldrugsurvey.com/wp-content/
uploads/2016/06/TASTER-KEY-FINDINGS-FROM-GDS2016.pdf
PREVALENCE AND CURRENT SITUATION 
Global Drugs  
Survey 2016
The findings of the world’s biggest drug survey, the Global 
Drug Survey (GDS) 2016, were published on 14 June.1 GDS 
is an ‘independent global drug use data exchange hub 
that conducts university ethics approved, anonymous 
online surveys’.1 It is made up of experts from the fields of 
medicine, toxicology, public health, psychology, chemistry, 
public policy, criminology, sociology, harm reduction and 
addiction. They aim to ‘help people and communities reduce 
the harm associated with the use of drugs regardless of 
their legal status, by sharing information in a credible and 
meaningful way’.1 
The survey explored patterns of use, harms, health and 
well-being experienced by a range of users. The survey was 
translated into 10 languages and had 101,313 respondents 
from over 50 countries. Seven hundred and seven 
respondents were from the Republic of Ireland. The authors 
identified a number of methodological issues that should be 
taken into consideration when looking at their findings: 
• The findings were not national estimates of drug use 
prevalence. 
• GDS used non-random, opportunistic sampling methods to 
recruit large numbers of people who use drugs.
• The survey recruited younger, more involved, and often 
hidden drug-using populations than other surveys. 
Dr Deirdre Mongan of the 
HRB, lead author of Overview 
of alcohol consumption, 
alcohol-related harm and 
alcohol policy in Ireland
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infectious diseases
The Irish Penal Reform Trust launched a new report, Improving 
prison conditions by strengthening the monitoring of HIV, 
HCV, TB and harm reduction: mapping report - Ireland, on 
23 June.1 The report forms part of the EU co-funded project, 
Improving Prison Conditions by Strengthening Infectious 
Disease Monitoring, which was implemented under the lead 
of Harm Reduction International.2 The project aims to reduce 
the ill-treatment of persons in detention and improve prison 
conditions through improved and standardised monitoring 
and inspection mechanisms on HIV, HCV and TB. This broader 
research informed the development of a user-friendly tool3 to 
help generate better informed, more consistent, and sustained 
monitoring of these diseases and harm reduction in prisons by 
national, regional and international human rights-based prison 
monitoring mechanisms.
The Irish report presented the findings of a national mapping 
exercise carried out to investigate available standards relating 
to human rights, infectious diseases and prison monitoring. 
It described the evolution in Ireland of the healthcare and 
prison systems; illicit drug use and the related legislative and 
policy context; and human rights, particularly in the context 
of judicial care. It then explored the situation in relation to 
infectious diseases among prisoners. Information was collected 
through a literature review, analysis of public documents, 
Freedom of Information requests, and consultation with 
experts in the prison service. 
Among the key findings was that the Irish Prison Service’s (IPS) 
provision for HIV and hepatitis C prevention measures did not 
meet the standards of best practice models found elsewhere 
in Europe and North America. Furthermore, the IPS did not 
fulfil its stated objective of providing primary healthcare 
(prevention, treatment and health rehabilitation) to offenders 
of at least an equivalent standard to that available to the 
general population. The authors argued that the IPS’s response 
to the HIV and hepatitis C crisis fell ‘far short’ of this standard. 
In terms of surveillance, they noted that while the Health 
Protection Surveillance Centre collected and collated data 
on notifiable diseases nationally, it was not possible for the 
authors to distinguish between those identified in the prison 
setting and the general population. They maintained that while 
some progress had been made in the adoption of monitoring 
mechanisms for infectious diseases in Irish prisons, it was 
less than sufficient or consistent in meeting the standards of 
human rights-based prison monitoring. 
The report identified a number of monitoring mechanisms 
for Irish prisons. These include the Inspector of Prisons, 
prison visiting committees, and the European Committee for 
the Prevention of Torture. All of these had been critical of 
conditions in Irish prisons. The authors also concluded that 
Ireland’s ongoing failure to have ratified the Optional Protocol 
to the Convention Against Torture presented a threat to the 
protection of the human rights of prisoners in Ireland.  
Presentations were also made at the launch by Dr Joe Barry, 
Clinical Professor in Public Health Medicine, Trinity College 
Dublin; Fergal Black, Director of Care and Rehabilitation at the 
Irish Prison Service; Emmett Conroy, prison nurse with the 
Irish Red Cross prison programme; and Judge Michael Reilly, 
Inspector of Prisons.
Lucy Dillon
1  MacNamara C, Varley L, Mannix McNamara P (2016) Improving 
prison conditions by strengthening the monitoring of HIV, HCV, 
TB and harm reduction: mapping report - Ireland. Dublin: Irish 
Penal Reform Trust. http://www.drugsandalcohol.ie/25635 
2  Sander G (2016) HIV, HCV, TB and harm reduction in prisons: 
human rights, minimum standards and monitoring at the 
European and international level. London: Harm Reduction 
International. 
3  Sander G (2016) Monitoring HIV, HCV, TB and harm reduction 
in prisons: a human rights-based tool to prevent ill treatment. 
London: Harm Reduction International.
Developing inside: 
transforming prison 
for young adults
Introduction
On 31 May 2016, the Jesuit Centre for Faith and Justice 
published a report that examined the needs, circumstances 
and conditions experienced by young adults (18-24 years) 
within the Irish prison system.1 The report was applauded 
by the Irish Penal Reform Trust (IPRT) as their own report in 
2015 drew similar conclusions.2,3
Young adults in prison: why are they unique?
Drawing on theory and research from the fields of criminology, 
sociology and psychology, it is argued that young adults aged 
18 to 24 form a unique but distinct group, and in consequence 
should be treated differently to older prisoners. 
Characteristics of this cohort include: 
• During the transition, biological and psychological 
developments can continue for some until their mid-
twenties.
• They experience changes in key areas of life, such as 
education, occupation, finances, living arrangements  
and romantic relationships.
• Most grow out of crime and will have stopped altogether 
by the time they are 30.
• They are more malleable and susceptible to peer 
influence.
• They are more likely to behave in a manner that will  
bring them into contact with the justice system.
• There is a higher level of risk taking; impulse control does 
not fully develop until mid-twenties.
• Their lack of maturity diminishes their ability to 
understand and participate in justice proceedings.
• They are not as equipped to plan ahead, reason, think 
abstractly or anticipate consequences.
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Notably, some behaviours and levels of maturity displayed by 
this cohort may resemble adolescence and may result in an 
assumption that this phase is an extension of adolescence. 
However, Jeffrey Arnett, who coined the term ‘emerging 
adulthood’ to represent this phase of development, defines 
it as a period that is ‘much different from adolescence, 
much freer from parental control, much more a period 
of independent exploration’ (p. 4).4 Proponents of the 
adolescent/emerging adulthood distinction argue that it is 
harmful to treat young adults as adults, particularly within 
the criminal justice system. 
Young adults in prison in Ireland:  
historical review
The report provides an overview of the treatment of young 
adults within the Irish justice system since the 19th century. 
An important point to note is that historically there has been 
fluidity in the age classification of young offenders, with an 
acknowledgement that children on reaching the age of 18 do 
not become adults overnight. 
Young adult prisoner: Irish context
A major finding of the report is that young adults are 
overrepresented in Irish prisons. Centred on data from the 
Irish Census of Population 2011, young adults represent 
approximately 11.94% of the adult population nationally. 
However, within prison populations young adults represent 
24% of individuals committed, 20% of those sentenced to 
prison and 26% of prisoners on remand (p. v).1 Notably, the 
overrepresentation is more apparent in young adults aged 21 
to 24, who represent 14.7% of the prison population but only 
5% of the general population.
International responses
Despite the existence of international standards and 
guidelines, countries vary in their responses to the detention 
of young adults.5,6,7 In comparison to other European 
countries (e.g. Germany, Northern Ireland, Scotland, 
Switzerland, Sweden and Turkey), Ireland does not fare well 
in its treatment of offenders aged 18 to 24.1 The Committee 
of Ministers of the Council of Europe issued the European 
Rules for Juvenile Offenders Subject to Sanctions or Measures 
(ERJOSSM) to European states in 2009.8 This document 
provides guidance on regimes that are best suited to young 
adult offenders where detention is used as a last resort. 
Recommendations
It is recommended that Ireland should avail of an alternative 
approach based on principles of education, rehabilitation 
and reintegration, where continuity of care of young adult 
offenders is guaranteed. A number of recommendations for 
reform have been put forward:
• There should be recognition that young adults (aged 
18 to 24) are a distinct group who should be under the 
remit of the Irish Youth Justice Service.
• Ireland should aim to reduce the number of young adults 
in prison.
• Young adults should be accommodated in detention 
centres that are humane and designed specifically for 
them and their age group.
• Young adults that are detained and prison officers should 
be in settings where they both feel safe.
• There should be greater accessibility to specialised 
services within prison and upon release in the 
community.
• A new regime for young adults in prison should be 
provided.
• Extended lock-up and ‘basic’ regime standards should 
be eradicated. On committal to a prison, young adults 
should be placed in the ‘enhanced’ accommodation 
standard (p. 67).1
• Young adult offenders should be included in operational 
decision-making of the detention centre and prison.
• There should be a reduction of remand. However, when 
necessary, all detention centres should have dedicated 
remand facilities.
• Motivation and support to abstain from drugs in the 
prison setting should be provided, while also providing 
harm reduction measures.
• Training of prison staff should be enhanced and avail 
of an evidence-based approach that is based on best 
international policy and practice.
Ciara H Guiney
1  Jesuit Centre for Faith and Justice (2016) Developing inside: 
transforming prison for young adults. Dublin: Jesuit Centre for 
Faith and Justice. Retrieved 5 August 2016 from http://www.
drugsandalcohol.ie/25588/ 
2  Irish Penal Reform Trust (IPRT) (2016) IPRT welcomes report by 
the Jesuit Centre for Faith and Justice into the needs of young 
adults (18-24) in prison [online]. Retrieved 5 August 2016 from 
http://www.iprt.ie/contents/2918 
3  Irish Penal Reform Trust (IPRT) (2015) Turnaround youth: young 
adults (18–24) in the criminal justice system. The case for a 
distinct approach. Dublin: IPRT. Retrieved 5 August 2016 from 
http://www.drugsandalcohol.ie/23921/ 
4  Arnett JJ (2004) Emerging adulthood: the winding road from 
the late teens through the twenties. Oxford: Oxford University 
Press. Retrieved 5 August 2016 from http://jeffreyarnett.com/
EmerAdul_Chap1.pdf
5  Transition to Adulthood Alliance (2010) Young adults and 
criminal justice: international norms and practices. London: 
Transition to Adulthood Alliance. Retrieved 5 August 2016 from 
http://www.t2a.org.uk/wp-content/uploads/2011/09/T2A-
International-Norms-and-Practices.pdf
6  Council of Europe (2003) New ways of dealing with juvenile 
delinquency and the role of juvenile justice. Strasbourg: Council 
of Europe Publishing. Retrieved 5 August 2016 from https://
www.crin.org/en/library/legal-database/council-europe-
recommendation-rec200320-concerning-new-ways-dealing-
juvenile
7  Dünkel F and Pruin I (2012) Young adult offenders in juvenile and 
criminal justice systems in Europe. In Lösel F, Bottoms A and 
Farrington DP (eds) Lost in transition: young adult offenders in 
the criminal justice system. Abingdon: Routledge. 
8  Council of Europe (2009) European rules for juvenile offenders 
subject to sanctions or measures. Strasbourg: Council of Europe 
Publishing. Retrieved 5 August 2016 from https://book.coe.int/
eur/en/children-s-rights-and-family-law/4221-european-rules-
for-juvenile-offenders-subject-to-sanctions-or-measures.html 
Developing inside: transforming 
prison for young adults continued
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16 Factors influencing 
reunification 
between NDTC 
service users and 
their children in care
Social workers from the National Drug Treatment Centre 
(NDTC) recently examined the issue of care admissions of 
children of parents attending the NDTC.1 They outline how 
it is well recognised internationally that misuse of drugs 
by parents can have detrimental effects on child welfare, 
including a higher risk to the child of addiction in later life. 
Previous studies in the Irish context are limited in number, 
but several studies have shown a high proportion of children 
taken into care among cohorts of drug users and homeless 
individuals in Dublin. The Health Service Executive (HSE) 
reported in 2011 that the primary reason for admission to 
care of 12% of children was a family member with drug or 
alcohol misuse. The authors also note how other studies 
show that drug-using parents can be motivated to provide 
adequate care for their children, and highlight how a 
combination of other factors, such as poverty, homelessness, 
mental health issues, and lack of family and social supports 
contribute to children being admitted to care.
The authors note that a primary focus of social work is 
maintaining family unity. Where children are admitted into 
care, maximising the chances of reunification is key to 
addressing this issue. The study consisted of two parts. 
Firstly, the authors retrospectively analysed data on child 
admissions to care for service users of the NDTC for the 
period 2001-2010. The NDTC cares for an average of 550 
problem opiate users. Variables recorded included whether 
or not the placement in care was within the extended 
parental family; admissions shortly after birth; and whether 
or not the children remained in care after one year.
Secondly, the authors asked the social work team at the 
NDTC to identify factors that they felt contributed to 
reunification within the first 12 months. Service users who 
had their children returned within 12 months were also 
asked to identify the factors that assisted reunification. This 
was done through providing participants with a list of seven 
factors chosen by the authors and allowing the participants 
to prioritise the factors from 1 to 7.
Arrangements where children were being cared for informally 
within the extended family were not recorded nor were 
reunifications after 12 months. The authors note that these 
kinds of reunifications were anecdotally accepted to be 
low in number. The authors also point out that reunification 
within 12 months is not a guarantee of future family stability, 
and that readmissions to care do occur. 
Results
Over the period 2001-2010, 142 children of service users 
were admitted to care. Sixty-one (43%) admissions to care 
came under section 36 of the Child Care Act 1991. This Act 
allows for children to be placed in care with a relative or 
family friend, assuming some initial criteria have been met. 
This can be done voluntarily or by court order. Interestingly, 
the national figures from 2011 indicate 29% of admissions 
to care were under section 36. While noting the potentially 
positive benefits of children being cared for by family 
members or friends, the authors warn that evidence suggests 
issues with these scenarios include reluctance to allow social 
work involvement, low levels of support offered, and carers 
sharing a similar background to parents.
The authors report that 46 of the 142 children were admitted 
to care shortly after birth. They take into account some 
anecdotal factors that appear associated with these early 
admissions to care, including illicit drug use during the 
pregnancy, the child exhibiting withdrawal symptoms after 
birth, and chaotic behaviours of the service user (e.g. 
address changes, not meeting appointments, etc.). The 
authors note the harm of separation at this early point, and 
how it is important to maintain frequent appropriate access 
to enhance the chances of reunification.
Of the 142 children taken into care during the period, 120 
had not been reunified with their parent(s) 12 months later. 
This means that only 21 children (14.7%) had been returned to 
the care of their parent(s) after 12 months. This is contrasted 
with 34% of children taken into care nationally in 
2011 being reunified within 12 months. 
The social work team at the NDTC identified progress in 
treatment as the main factor resulting in reunifications. 
Only six parents were interviewed for the study, with four 
identifying maintaining bond/contact with children in care as 
the main factor in their reunifications. A full list of factors is 
provided in Table 1. 
Table 1  Reunification factors prioritised by social workers  
and parents
Priority Social workers Parents
1 Progress in treatment Maintaining bond/
contact with child(ren) 
in care
2 Maintaining bond/
contact with child(ren) 
in care
Progress in treatment
3 Support of partner/
extended family
Direction and input from 
family court
4 Constancy of key 
personnel in the 
reunification process
Support of partner/
extended family
5 Securing appropriate 
accommodation
Securing appropriate 
accommodation
6 Ongoing interagency 
liaison
Constancy of key 
personnel in the 
reunification process
7 Direction and input from 
family court
Ongoing interagency 
liaison
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The authors express the hope that interventions like these 
could improve reunification rates and help meet the key 
principle of family reunion. They also highlight the need for 
enhanced contact between parents and children in care, 
believing it could increase the rate of reunification.
Martin Grehan
1  McGivern A and McDonnell C (2015) Vulnerable families and  
drug use: examining care admissions of children of parents 
attending an Irish drug treatment facility. Irish Social Worker, 
Spring: 17-23. http://www.drugsandalcohol.ie/24712
The authors note that specialist interventions in the US 
(independent recovery coaching) and the UK (court-
appointed multidisciplinary team) have been shown to 
raise the rate of reunification in cases like these. In Ireland, 
Ashleigh House, part of Coolmine Therapeutic Community, 
is the only residential service in Ireland for women requiring 
treatment and their children. Women can either live with 
their children or have weekend access, or work towards 
access, depending on their circumstances. 
The majority of participants (82%) were smokers. Of the 35 
current illicit drug users, 21 (60%) were currently injecting 
one or more drugs intravenously, primarily heroin (95%), and 
had injected on average on 61 of the previous 90 days. Of the 
21 injecting drug users, 81% reused their own needle/syringe 
and 66% shared another drug user’s needle/syringe. Almost 
all (n=20) had used needle exchange services in the previous 
six months. Polydrug use was reported by 34% of all illicit 
drug users.
Six per cent of participants were HIV positive and this rose to 
9% among current drug users. Moreover, 37% of illicit drug 
users were positive for hepatitis C (23% of all participants) 
and 3% were positive for hepatitis B. Eighty per cent of illicit 
drug users had been tested for HIV and hepatitis B and C. 
Current and previous drug users were five times more likely 
to have multimorbidity than those who had never taken 
drugs. Current drug users were four times more likely to 
report poor perceived quality of life than non-drug users, 
while there was no difference between non-drug users and 
previous drug users.
Uptake of primary care services was high among all 
participants. GP services were used by 86% of illicit drug 
users and Safetynet nurses by 71%. A total of 46% of current 
drug users were using methadone, while a further 11% were 
on the waiting list for methadone treatment. Current drug 
users were less likely to avail of mental health or dental 
services than those who did not use illicit drugs.
The authors highlight the high level of drug use among the 
homeless population and the negative impact this has on 
their health and perceived quality of life. They illustrate 
the importance of services such as Safetynet in providing 
accessible primary care services which meet the specific 
health needs of this population. 
Margaret Curtin 
1  O’Brien KK, Schuttke A, Alhakeem A, Donnelly-Swift E, Keogh 
C, O’Carroll A, O’Sullivan K, Galvin R and Fahey T (2015) Health, 
perceived quality of life and health services use among 
homeless illicit drug users. Drug and Alcohol Dependence, 154: 
139-145. http://www.drugsandalcohol.ie/24384/ 
2  SLÁN (Survey on Lifestyle and Attitude to Nutrition) is a four-
yearly survey commissioned by the Department of Health and 
designed to produce baseline information for the ongoing 
surveillance of health and lifestyle behaviours in the Irish 
population. For further information, visit http://www.ucd.ie/
issda/data/surveyonlifestyleandattitudestonutritionslan/
Homeless drug 
users: their health, 
perceived quality  
of life and use of 
health services 
The report of a study comparing the physical and mental 
health, perceived quality of life, and health services use 
among homeless illicit drug users and homeless non-drug 
users was recently published.1 The cross-sectional study was 
conducted with 105 participants, all of whom were recruited 
through Safetynet Ireland. Safetynet operates 14 clinics across 
Dublin, located in homeless shelters and foodhalls, which 
provide free primary care services, including access to GPs, 
nurses and drug workers, in an environment that is accessible 
to those who are homeless or at risk of homelessness. Study 
participants were recruited at four of these clinics using a 
gatekeeper mechanism whereby the patient was informed of 
the study by a staff member and, if willing to be involved, they 
were then introduced to the researchers.
A questionnaire consisting of 133 items was used. It included 
standardised tools such as AUDIT-C to measure problem 
drinking, GAD-7 for anxiety and PHQ-9 for depression. 
Quality of life was assessed using the five-point scale 
from the SLÁN study.2 Participants were also asked if they 
were current, previous or never illicit drug users. Logistic 
regression was used to determine if drug use was associated 
with multimorbidity, anxiety and/or depression, poorer 
perceived quality of life or increased use of health services. 
Age, gender, alcohol use and smoking were also considered.
Of the 105 participants, 35 were current illicit drug users 
and 28 had used drugs in the past. The majority (75%) 
were male and 58% were under 40 years of age. The main 
accommodation type was hostel (43%) and 60% had been in 
their current accommodation for between 1 and 12 months. 
The demographic characteristics were similar for both 
drug and non-drug users, except that a higher proportion 
of current drug users as opposed to non-drug users were 
Irish (82% vs 70%) and were more likely to be current 
alcohol drinkers (94% vs 58%); fewer current drug users had 
completed third-level education (3% vs 13%).
Reunifying NDTC service users 
and their children in care continued
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16 Recording of deaths
The recording of suicide and sudden unexpected deaths 
that may have been the result of suicidal or self-harming 
behaviour poses challenges to understanding the true 
incidence of suicide in a community at a particular time, as 
official figures are measured by calendar year and remain 
provisional for up to two years post-event. This research has 
provided DMHS with a ‘real time’ database with information 
on sociodemographic, psychosocial and psychiatric risk 
factors that may have contributed to the untimely deaths 
or suicides of those in its care over the period considered. 
The maintenance of this data will inform policy and resource 
planning and facilitate a targeted response to suicide 
contagion and emerging suicide clusters.
Key findings 
Of the 34 deaths examined: 
• 67.8% were men.
• The men were younger than the women, with mean ages 
of 41.4 years and 44 years, respectively. 
• Clinical files showed cause of death as overdose of 
medication or drugs (n=15, 44%), hanging (n=14, 41%)  
and drowning (n=5, 15%). 
• Of those who died by intentional overdose, the majority 
involved prescribed medication, with toxicology results 
of 10 cases also indicating substantial amounts of alcohol 
in both blood and urine at time of death. Most recent 
figures from the National Drug-Related Deaths Index 
(NDRDI) show that two-fifths (41%) of poisonings in 2013 
involved benzodiazepines.2 
• Almost half were known to abuse both drugs and alcohol 
prior to death (n=16, 47%) and a further six had abusive 
or dependent issues with a single substance.
Figure 2  Reported substance abuse of the deceased
Source: A study of untimely sudden deaths and people who took their lives 
while in the care of the Donegal Mental Health Service (2016, p. 30, Figure 8)
Suicide and untimely 
sudden deaths in 
the Donegal Mental 
Health Service
In 2014, the HSE Donegal Mental Health Service (DMHS) 
commissioned a study which sought insight into an increasing 
number of premature deaths among its service users.1 The 
research, which was funded by the National Office for 
Suicide Prevention (NOSP) and conducted by a team from 
the National Suicide Research Foundation (NSRF), examined 
34 deaths among those in the care of the DMHS between 
October 2011 and May 2015. The study has produced a 
number of evidence-based recommendations to improve 
the assessment and management of people at risk of suicidal 
behaviour in a mental health service setting.
Suicide Support and Information System-
Psychological Autopsy Model 
The Suicide Support and Information System-Psychological 
Autopsy Model (SSIS-PAM) used in this study was developed 
to prevent suicide by proactively facilitating access to 
support for the bereaved, while at the same time obtaining 
information on risk factors associated with suicide and 
deaths classified as open verdicts. Data were collected 
from multiple sources to corroborate the clinical history of 
the deceased as well as offering support to family members 
following such a tragic event. Twenty-four family informant 
interviews were conducted, with 21 families providing 
consent for the researchers to contact GPs involved in 
the care of the deceased. Thirteen GPs completed and 
returned questionnaires.
 
Figure 1  SSIS–PAM access to multiple sources of information
Source: A study of untimely sudden deaths and people who took their lives 
while in the care of the Donegal Mental Health Service (2016, p. 20, Figure 2)
 
Medical
Records
Coroner’s records 
and postmortem 
reports
Healthcare 
professionals
Close family  
members/ 
friends
  Drugs only (n<5)
  Alcohol only (n<5)
  Both (n=16)
  Neither (n=12)
6%
12%
47%
35%
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Recommendations
The study makes six recommendations, covering 19 actions, 
based on its findings in relation to the characteristics of the 
deceased, patterns regarding contact with mental health 
services, and the needs of families bereaved by suicide. 
These can be summarised as follows:
1  Improve clinical practice to increase understanding 
among mental health service staff about service user 
suicide and self-harm risk that is mindful of gender, age 
and other factors (such as cases of dual diagnosis) which 
may influence the risk of premature death.
2 Prioritise uniformity of good practice. 
3  Foster communication and engagement with family 
members.
4  Improve the service response to family members 
following the death of a service user.
5 Improve media reporting of suicide.
6 Implement the Suicide Support and Information System.
According to Dr Clifford Haley, Executive Clinical 
Director, Donegal Mental Health Services: ‘This data set 
of consecutive untimely sudden deaths will contribute 
to suicide research internationally, but most importantly 
it helps cast light onto what must be done to provide 
effective suicide prevention in Ireland.’ 
Sarah Fanagan 
1  Corry C, Arensman E and Williamson E (2016) A study of untimely 
sudden deaths and people who took their lives while in the care 
of the Donegal Mental Health Service. Cork: National Suicide 
Research Foundation. http://www.drugsandalcohol.ie/25727/
2  Health Research Board (2015) Drug-related deaths and deaths 
among drug users in Ireland: 2013 figures from the National Drug-
Related Deaths Index. Dublin: Health Research Board. http://
www.drugsandalcohol.ie/24676
• 76.5% had a history of self-harm (n=26).
• The majority had a history of at least one voluntary or 
involuntary inpatient psychiatric admission (n=31).
• Psychiatric diagnosis was confirmed in all 34 cases, with 
85% also meeting criteria for a secondary disorder; 47% 
had a primary diagnosis of depressive disorder (n=16) and 
a secondary diagnosis of substance abuse was recorded 
in 47% of cases (see Figure 3).
• 82% were being prescribed medication for mental illness 
preceding death. Information gathered on these cases 
included reckless behaviour, such as hoarding large 
supplies while requesting repeat prescriptions, and selling 
or exchanging prescribed medication for illegal drugs.
• The majority (n=18) had family members with known 
mental health issues, with depression and substance 
abuse the most common.
• 44% of case files contained incomplete assessments 
of suicidal risk, which was recorded in a way that was 
not considered to be informative of the service user’s 
suicidal state. In 56% of case files, appropriate evaluation 
was conducted and made available in accordance with 
best practice principles.
Media reporting of suicides and unexpected 
sudden deaths
The National Media Monitoring Agency conducted a search of 
media outlets in County Donegal and nationally to determine 
the extent of media reporting of the cases of suicide and 
probable suicide examined in this study covering the period 
January 2011 to March 2015.
• Overall, journalistic reporting was mindful of the effect 
that oversensationalised reports can have on family and 
friends of the deceased and wider community.
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Figure 3  Primary and secondary psychiatric diagnoses among the deceased 
Source: A study of untimely sudden deaths and people who took their lives while in the care of the  
Donegal Mental Health Service (2016, p. 37, Figure 16)
Suicide and untimely sudden 
deaths in the Donegal Mental 
Health Service continued
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16 Second choices included ‘have enough already’ (16.3% 
2015; 11.8% 2006) or that they had reached their ‘protocol 
maximum’ (27.2% 2015; 16.5% 2006). GPs that did not have 
patients currently enrolled in the MTP were invited to provide 
more information as to why this was the case. In 2015, 85% of 
these GPs reported that there was either no demand for the 
service in their area or they had never been asked to take on 
any patients. This was largely similar to 2006, where 83% of 
GPs cited the same reasons. Other reasons for not engaging 
with the MTP included a fear of violence, alienating private 
patients, a lack of knowledge, lack of community supports, and 
personal reasons such as a lack of empathy with addicts and 
discomfort with the topic of addiction. 
Attitude towards the MTP and  
additional services
In general, the majority of GPs who had patients in the 
MTP in 2006 and 2015 had a positive attitude towards the 
programme. GPs agreed that the MTP eliminates chances of 
double scripting, allows for a good relationship with patients, 
improves the health of the patients and reduces criminality. 
Alongside the positive feedback for the MTP, GPs identified a 
lack of access to assessment and support services (including 
community liaison officers, literacy support, alcohol support 
services, and return to employment services) for patients 
receiving MMT. These were common issues between the 
2006 and 2015 surveys. Furthermore, GPs highlighted a 
lack of accessible information about the types of services 
that are currently available and also the lack of a referral 
mechanism which can support the transfer of stabilised 
patients to primary care settings.
When asked to rank a list of services which they deemed 
necessary to further support the MTP, GPs in both 
years selected addiction counselling as their preferred 
choice (46.5% 2015; 51.7% 2006). GPs felt that inpatient 
rehabilitation detoxification beds, employment schemes 
and drop-in/social centres would also benefit patients in 
the MTP. The authors noted that the percentage of GPs who 
selected employment schemes and drop-in/social centres 
as their primary choice between 2006 and 2015 increased 
from 8.9% to 21.2% and 0.7% to 11.76%, respectively. 
Discussion
Overall, the authors noted that this study highlighted a 
favourable opinion of Irish GPs towards participation in 
the MTP and obstacles and attitudes towards the provision 
of the programme. Notably, there was a perceived rise in 
the scale of local illicit drug use between 2006 and 2015. 
In addition, GPs provided a useful insight into the range 
of supplementary supports and services they believe are 
necessary for correct care of patients on the programme.  
By comparing survey results from 2006 and 2015, the authors 
found that the majority of GPs’ attitudes towards the MTP 
have remained largely positive. The authors concluded that 
there is a need for greater efficiency of referral mechanisms 
for stabilised patients and greater implementation of 
psychosocial, vocational and detoxification supports 
warranted in the Irish primary care setting. 
Thérése Lynn
1  Delargy I, O’Shea MT, Van Hout MC, Collins C (2016) General 
practitioner perspectives on and attitudes toward the 
methadone treatment programme in Ireland. Heroin Addiction 
and Related Clinical Problems, 18(4): 43-50. http://www.
drugsandalcohol.ie/25746/
RESPONSES 
Surveys reveal  
GPs have positive 
attitude towards 
Methadone 
Treatment 
Programme
The Methadone Treatment Programme (MTP) offers 
methadone maintenance treatment (MMT) to heroin addicts 
in Ireland and was introduced across the country in 1998. 
Given the central role of the GP in the delivery of care in 
the Irish health landscape, the MTP is regulated by the Irish 
College of General Practitioners (ICGP). The aim of this 
study1 was to assess and compare GP perceptions of the 
scale of local illicit drug use, attitudes towards and obstacles 
in the provision of methadone treatment, and the preferred 
adjunct modalities alongside MMT. 
To achieve this aim, two surveys were carried out with 
GPs in 2006 and 2015. The survey contained a series of 
descriptive and open-ended questions and was emailed to 
all GPs registered on the MTP database, irrespective of their 
current level of engagement in the MTP. The authors stated 
that, where possible, comparisons were drawn between the 
opinions of GPs who had patients receiving MMT in both 
2006 (n=147) and 2015 (n=170). 
Results
In terms of response rate, 207 out of 600 (34.5%) GPs 
responded in 2006 and 217 out of 949 (22.87%) GPs 
responded in 2015. The authors acknowledged the response 
rate as a limiting factor in the study but outlined that this 
response rate is typical of the GP population. The profile of 
participating GPs as predominantly male and aged between 
35 and 60 remained largely unchanged between 2006 and 
2015. Notably, there was an increase of 57% in the number of 
female participants in 2015. 
Perception of the illicit drug problem  
and provision of MTP
When asked their opinion on the extent of illicit drug use 
in their area, 66.5% of GPs felt it was a major problem. This 
perception was worse compared with 2006 (53.2%). By linking 
perception to demographic location, the authors found that 
the majority of GPs that reported illicit drugs as a major 
problem were practising in urban locations. Similarly, the 
majority of GPs from rural areas reported minimal problems 
with illicit drug use in their practices. Notably, no statistical 
significance was observed between these two variables. 
GPs that had patients enrolled in the MTP were asked to 
provide details about any perceived obstacles to recruiting 
new patients into the programme. The majority of GPs (54% 
2015; 71.8% 2006) cited either no obstacles or no referrals in 
response to this question. 
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taken is required to have an effect or cause serious harm. 
Many countries are now in the process of controlling these 
substances.
Addiction to benzodiazepines was also discussed with a 
warning that insufficient attention is being paid to this issue. 
Novel benzodiazepines, such as etizolam and phenazepam, 
are widely available, and in many countries are not yet 
controlled under drugs legislation. Many products containing 
these drugs are manufactured to look like legitimate 
pharmaceuticals, e.g. diazepam and alprazolam.
Across Europe, there is an increasing trend in injecting NPS. 
Hungary has reported an increase in hepatitis C infections in 
2014 (24%-48.8%) with the highest prevalence rate around 
NPS injectors (73.9%). Many users at drug treatment centres, 
who were injecting, reported that their first injecting 
experience was with an NPS.
Guidelines for front-line staff
The EMCDDA reported on data collected across Europe with 
respect to current approaches and challenges in responding 
to NPS-related harm. Services and guidance for dealing with 
these substances vary from country to country with staff 
relying on knowledge of traditional drugs to tackle NPS. 
Those involved in intervention reported a need for training 
and NPS-specific guidance. Problems associated with drug 
treatment were also highlighted with services not available in 
rural areas or to recreational users.
In response to these issues, a guidance document published 
by the NEPTUNE project, entitled Guidance on the clinical 
management of acute and chronic harms of club drugs and 
novel psychoactive substances, is available on the EMCDDA 
website.2 It offers information and guidelines for front-line 
medical staff and those working in addiction services on how 
to tackle NPS-related issues.
Internet forums
Since the introduction of generic and specific psychoactive 
substances legislation in many countries, the number of high 
street shops selling NPS has dramatically reduced. This in 
turn has resulted in a vast online market for these products. 
The Internet is also a place where users of NPS communicate 
with each other to make purchases, discuss products 
and dosages, and share experiences. Many researchers 
presenting at the conferences are using these online forums 
to analyse the information being shared by NPS users. This 
information provides a valuable insight into different groups 
from recreational users who are looking to experiment and 
relax to dependent or harmful users. Many online surveys 
have also been conducted across Europe, where NPS users 
answer specific questions on their usage and experiences. 
Recreational users reported taking NPS in a social setting to 
get high and bond with friends. However, only 50% of users 
had any knowledge of safe dosages.
Also discussed was the CASSANDRA project (Computer 
Assisted Solutions for Studying the Availability aNd 
Distribution of novel psychoActive substances), which is a 
multidisciplinary project that uses technology and social 
media to investigate the supply chain and diffusion of NPS.
4th International 
Conference on 
Novel Psychoactive 
Substances, Budapest, 
30-31 May 2016
On 30 and 31 May 2016, the 4th Annual Conference on Novel 
Psychoactive Substances (NPS) took place in Budapest, 
Hungary.1 There has been a dramatic increase in the number 
of NPS that have emerged worldwide in recent years. The 
European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) monitors 560 substances with approximately 100 
reported for the first time in 2015. Therefore, it is imperative 
to share accurate, evidence-based information at an 
international level on the analysis of these substances and 
their effect on society. This conference, now in its fourth 
year, is a forum to foster collaboration between all those 
working in the area of NPS from law enforcement, forensic, 
clinical and toxicological analysis to research, front-line 
medical staff, addiction services and community workers.
Synthetic cannabinoids 
A common theme in many of the presentations was the 
harm being caused by synthetic cannabinoids in Europe and 
worldwide, e.g. users reporting that the adverse side-effects 
far outweigh the feeling of well-being when the substances 
are taken initially. In addition, more negative side-effects 
are being experienced with synthetic cannabinoids than with 
other types of NPS, e.g. synthetic cathinones. 
A study by Waterford Institute of Technology entitled 
‘Dependent user experiences of withdrawal from herbal 
smoking mixtures’ was presented at the conference. The 
study was carried out in a settled Traveller community in 
the border counties in Ireland, where littering of herbal 
mixture product packaging was widespread. The packaging 
labelled Clockwork Orange and Happy Joker contained 
herbal material that was found to contain 5F-AKB-48 and 
5F-PB-22. Users reported dependent use with intense 
cravings, compulsive behaviours and an inability to cease due 
to the fear of psychosis. The report recommends expedited 
responses from both addiction and mental health services.
New substances with potential for harm
New synthetic cathinones and cannabinoids are being 
identified in Europe and worldwide on a weekly basis. 
However, concern was raised by many speakers at the 
emergence of synthetic opioids and novel benzodiazepines. 
The synthetic opioids are a cause for concern with many 
overdoses and deaths reported in the USA, Canada 
and Europe. Examples of such compounds are fentanyl 
derivatives and analogues, such as acteylfentanyl, 
furanylfentanyl, ocfentanil, and compounds such as W-18, 
AH-7921, U-47700, MT-45, all of which have a much higher 
potency than morphine. Users believe they are buying 
heroin or oxycodone but the product in fact contains a 
synthetic opioid, where only a fraction of the dose usually 
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1  For more information on the conference and  
online access to presentations and posters, visit  
http://www.novelpsychoactivesubstances.org 
2  Guidance on the clinical management of acute and chronic 
harms of club drugs and novel psychoactive substances. Available 
online at http://www.emcdda.europa.eu/attachements.cfm/
att_236560_EN_UK10_NEPTUNE%20NPS%20guidance%20
(2015).pdf
Analysis
Analysis and identification of NPS continues to pose 
challenges for border control, forensic and toxicological 
services. These include developing new analytical methods, 
adding new substances to existing methods and sourcing 
reference standards. Many speakers emphasised the need 
for continued collaboration between testing laboratories and 
academic institutions to identify new substances, whether 
it is providing access to standards or scientific techniques, 
e.g. nuclear magnetic resonance (NMR) spectroscopy. This 
research is also being combined with pharmacological-based 
studies in order to evaluate the potential for harm of newly 
identified compounds. 
NPS Conference continued
be unfamiliar with their role. In 2015, nurses working in this 
area formed the Ireland Chapter of IntNSA, to become a 
part of a professional organisation founded in 1975 in the 
United States for nurses committed to the prevention, 
treatment and management of addictive disorders. These 
include alcohol and other drug dependencies, nicotine 
dependencies, eating disorders, dual diagnosis, multiple 
diagnosis, and process addictions, such as gambling. 
IntNSA’s mission is to advance excellence in nursing care 
for the prevention and treatment of addictions for diverse 
populations across all practice settings through advocacy, 
collaboration, education, research and policy development. 
IntNSA is engaged in a wide range of activities internationally, 
which has included hosting a symposium at the International 
Society of Addiction Medicine (ISAM) conference in 
Dundee in 2015. The Ireland Chapter was the first chapter 
established outside the United States and now has over 50 
Irish members. It aims principally to provide a professional 
support network for nurses and other disciplines working 
in the addictions field and across other areas of healthcare 
in Ireland. The Ireland Chapter of IntNSA also seeks to have 
addiction nursing recognised as a discipline within nursing. 
Membership is open to nurses registered with the Nursing 
and Midwifery Board of Ireland (NMBI) and student nurses, 
while associate membership is open to other disciplines 
and service users.3 Service users and nurses from addiction 
treatment and academic disciplines are represented 
on the board. The board members are Ann McGuire, 
Deirdre Carmody, Deirdre Lynne, Dr Gerry Moore, John 
Flanagan, Niall O’Connell and Peter Kelly. Opportunities for 
international collaboration are increasing, as there are now 
IntNSA chapters in The Netherlands and in Brazil, with a UK 
chapter currently being established. 
One of the main objectives of the Dublin conference, which 
had a capacity attendance, was to raise awareness of the 
value that nurses can bring right across the spectrum of 
treatment services and to increase dialogue with service 
users and other practitioners and academics in other 
disciplines. A panel discussion, chaired by Dr Siobhán 
O’Halloran, Chief Nursing Officer at the Department of 
Health, generated an interesting discussion around the future 
of addiction treatment in Ireland. 
Inaugural Irish 
conference for 
nurses in addiction 
services
The Ireland Chapter of the International Nurses Society on 
Addictions (IntNSA)1 held its inaugural conference in Dublin 
City University on 10 June 2016. The conference theme 
was ‘Hot topics in addiction’, where Irish and international 
speakers addressed several current issues, including the 
service user experience, chemsex, the role of the nurse in 
substance misuse, nurse prescribing, medically supervised 
injecting, and Irish and international policy developments. 
The conference was attended by the current president 
of IntNSA in the US, Dana-Murphy Parker, an Assistant 
Professor of Nursing at Drexel University in Philadelphia,  
Dr Carmel Clancy, Chair of the IntNSA International 
Task Force and Dr Chris Loth, President of the IntNSA 
Netherlands chapter, who was accompanied by two 
Netherlands IntNSA board members.2 
Nurses play an increasingly important role in the treatment 
and prevention of addictive disorders across a broad range 
of healthcare settings. Nursing education covers a range 
of academic and practical subject areas, including holistic, 
physical and mental healthcare, psychosocial interventions, 
self-awareness, ethics and pharmacology. The undergraduate 
nursing degree prepares nurses for practice in child health, 
midwifery, mental health and intellectual disability as well as 
general practice. Many of the skills gained before undertaking 
specialist postgraduate training are highly relevant in terms 
of meeting client needs across the spectrum of addiction 
treatment. Nurses’ professional registration also provides 
enhanced statutory protection for both employers and 
service users. 
However, the diverse nature of work in the addictions field 
in Ireland and the lack of opportunity for specialisation 
outside of Dublin have meant there is some ambiguity 
around the role of nurses in this field and its service value. 
In the workplace many nurses find themselves isolated 
from professional support in areas where employers may 
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Peter Kelly
1  Further details on IntNSA’s mission, vision and values are 
available online at http://www.intnsa.org/ 
2  Information on other speakers is available at https://www.dcu.
ie/snhs/news/2016/mar/international-addictions-conference.
shtml
3  Information on membership of the Ireland Chapter of  
IntNSA and conference speakers is available online at  
http://groupspaces.com/IrelandChapterofIntNSA/join/
In November 2015, representatives of the Ireland Chapter 
of IntNSA met with the then Minister for the National Drugs 
Strategy, Aodhán Ó Ríordán, and was the first nursing group 
to formally contribute to an Irish national drugs strategy 
via attendance at the Continuum of Care Focus Group. The 
focus for 2016/17 will be decided at our forthcoming AGM 
and we will explore opportunities to positively influence the 
nursing contribution to Irish addiction services.
Nurses in addiction services 
continued
Despite this, EEM is not common practice among 
organisations in Ireland. The authors highlight section 42 of 
the Irish Human Rights and Equality Commission Act 2014,4 
which instructs that public bodies ‘have regard to the need 
to: (a) eliminate discrimination, (b) promote equality of 
opportunity and treatment of its staff and the persons to 
whom it provides services, and (c) protect the human rights 
of its members, staff and the persons to whom it provides 
services’. The report states that without accurate EEM, 
public bodies will not be able to demonstrate that they have 
met these obligations. 
The report cites the national census, produced by the 
Central Statistics Office (CSO), and the National Drug 
Treatment Reporting System (NDTRS) as examples of good 
practice. The NDTRS has been recording ethnic identifiers 
since 2007. However, the report also states that often even 
the limited ethnic data available is not used to its full extent. 
While not unique to Ireland, the lack of EEM data inhibits the 
planning of effective services, monitoring access to them, 
and their outcomes.
Travellers and Roma themselves can be hesitant 
about disclosing their personal information for fear of 
discrimination and from lack of trust. However, research has 
shown that participation can be increased when the minority 
ethnic groups themselves are consulted and involved in the 
process of data collection itself from design, data collection 
and analysis. A participative and consultative approach has 
been shown to engender trust and increase participation 
in studies. Another barrier to EEM can be due to reluctance 
or discomfort on the part of the data collector to ask the 
question on ethnicity for fear of offending or from a lack of 
understanding the rationale for the question. This can be 
overcome with appropriate training, which should include 
cultural awareness and antiracism training.
Summary of recommendations 
1  Ethnic equality monitoring should be endorsed, 
promoted and supported at a senior level within State 
agencies. There should be a campaign to inform people 
of the important, human rights rationale for collecting 
ethnic data.
2  A National Steering Committee with responsibility 
for developing and monitoring a comprehensive EEM 
framework to include all relevant stakeholders should  
be set up. This group should ensure that ethnic 
categories develop over time in consultation with the 
appropriate groups.
Ethnic data 
collection and 
monitoring
Pavee Point Traveller and Roma Centre launched its new 
report Policy and practice in ethnic data collection and 
monitoring1,2 on Monday, 21 March to mark International 
Day for the Elimination of Racial Discrimination. A seminar 
was also held on the day, chaired by Anastasia Crickley, the 
Vice-President of the UN Committee for the Elimination 
of Racial Discrimination (CERD), with presentations from 
Lynsey Kavanagh, author of the report, and Andrew Millard, 
Equalities Intelligence Manager, Scottish Public Health 
Observatory. Diane Nurse, HSE National Lead for Social 
Inclusion, Primary Care Division, provided the closing 
comments to the seminar. Co-directors of Pavee Point, 
Ronnie Fay made opening comments, while Martin Collins 
officially launched the report.
This report was in response to the paucity of data in official 
statistics on ethnic minority groups in Ireland, particularly 
Irish Travellers and Roma. Ethnic equality monitoring (EEM) is 
defined as the systematic and regular collection of data on 
the ethnic composition of a population. It is 20 years since 
the European Commission against Racism and Intolerance 
(ECRI) at the European Commission first recommended 
that ethnic data be collected to help implement policies to 
combat racism. Since then, many national and international 
organisations have stressed the importance of accurate EEM 
to evaluate the outcomes of policies and strategies to tackle 
discrimination against Travellers and Roma. 
The United Kingdom is one of the few countries to have 
systemic EEM in place, with many other European countries 
slow to introduce EEM, often citing privacy, legal and moral 
issues as barriers. However, this report stresses that EEM 
data can be disaggregated and published in a manner that is 
appropriate and that protects the privacy of the individuals, 
but still provides useable data to inform policies and planning 
in order to provide appropriate services. 
EEM is not a simple solution to eradicate 
discrimination. It is a powerful tool that can 
highlight areas of concern, specifically processes of 
inequality and discrimination which otherwise may 
go undetected (Wagman, 2002, p. 16).3
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16 6  Timely, disaggregated data should be made readily 
accessible to all interested stakeholders biannually.
7  Resources should be available to enable collection of 
standardised ethnic data. 
Suzi Lyons
1  Pavee Point Traveller and Roma Centre (2016) Policy  
and practice in ethnic data collection and monitoring.  
Dublin: Pavee Point Traveller and Roma Centre.  
http://www.drugsandalcohol.ie/25325/
2  See videos of the presentations made on the day at http://www.
paveepoint.ie/project/ethnic-data-monitoring-initiative/
3  Wagman D (2002) Roma women in prisons. In Pavee Point 
(ed). Traveller proofing: within an equality framework. Dublin: 
Pavee Point Traveller and Roma Centre, pp. 15-17. http://www.
paveepoint.ie/wp-content/uploads/2013/11/Traveller-Proofing-
Equality-Framework.pdf
4  Irish Human Rights and Equality Commission (IHREC) Act (2014). 
Available online at http://www.ihrec.ie/about/ihrec-act-2014.html
3  The national committee should develop an EEM strategy 
in consultation with ethnic groups, to incorporate key 
performance indicators, deadlines and sufficient funding 
for any actions. 
4  All public sector organisations that collect data should 
provide training for staff in cultural awareness to enable 
them to collect ethnic data in an appropriate way and 
ensure that EEM is an integral part of the data collection 
process into the future.
5  Any State system or survey that collects routine data 
should include ethnic identifiers, using the standardised 
CSO classifications to ensure consistency. In particular, 
ethnic data should be disaggregated by gender to enable 
planning for appropriate services for minority women.
• To create a welcoming and inclusive environment, 
services should display LGBT posters where possible. 
LGBT issues should be included in the service ethos 
statement or equality policy, and in any service plans  
or evaluations.
• Partners and spouses of LGBT people should be included 
where possible and given the same consideration and 
rights as heterosexual partners or spouses.
• Service providers have a responsibility to ensure equal 
access to their service regardless of gender, sexual 
orientation, civil status, family status, age, disability, 
ethnicity, social class or religion. In order to measure equity 
of access, services need to monitor the ethnicity and sexual 
orientation of their clients. Guidance is available with regard 
to ethnic data collection, e.g., from Pavee Point,2 and 
examples of how to frame questions regarding self-defined 
gender identity and sexual orientation are contained in 
the questionnaire used by the National Drug Treatment 
Reporting System (NDTRS).3
Suzi Lyons
1  Gay and Lesbian Equality Network (GLEN) (2013) Lesbian,  
gay, bisexual and transgender service users: guidance for  
staff working in mental health services. Dublin: GLEN.  
http://www.mhcirl.ie/File/LGBT_SU_Guide_for_staff.pdf
2  Pavee Point Traveller and Roma Centre (2016) Policy and practice 
in ethnic data collection and monitoring: counting us in - 
human rights count! Dublin: Pavee Point Traveller and Roma 
Centre. http://www.paveepoint.ie/wp-content/uploads/2016/04/
Counting-Us-In-A4_WEB.pdf 
3  Health Research Board (2016) National Drug Treatment Reporting 
System Form. For more information, visit http://www.hrb.ie/
health-information-in-house-research/alcohol-drugs/ndtrs/
information-collected/ 
LGBT service  
users and mental 
health risks
Irish research has shown that lesbian, gay, bisexual and 
transgender (LGBT) people, particularly younger people, are 
at greater risk of experiencing mental health problems than 
the general population. In order to increase awareness of 
these risks among mental health staff, the Gay and Lesbian 
Equality Network (GLEN) in consultation with the Mental 
Health Commission (MHC) developed a guidance document.1 
It aims to help mental health staff provide more inclusive 
services to LGBT service users. While not specifically 
addressing addiction issues, the guide is very relevant to staff 
working in addiction services. 
The various steps needed to provide inclusive services to 
LGBT service users and their partners and families or chosen 
advocates are outlined in the document, which is available to 
download. Key considerations include the following:
• Most services have LGBT clients but their LGBT identity 
may or may not be related to the reason they are 
presenting to a service. Staff should not presume 
heterosexuality or predetermine a person’s gender, and 
the language used and questions asked by staff should 
reflect this. 
• Staff need to be familiar with the specific stressors and 
needs of LGBT clients, e.g. fear of coming out, isolation, 
lack of family support, homophobic bullying. Staff also 
need to be aware of the range of LGBT organisations 
that can support the specific needs of LGBT clients. 
Training can be provided for staff by LGBT organisations 
to facilitate this.
Ethnic data collection  
and monitoring continued
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Transsexual refers to people whose gender identity 
is opposite to the sex assigned to them at birth. 
Transsexual people may seek medical interventions, 
such as hormones and surgery, to make their bodies 
fit as much as possible with their preferred gender. 
The process of changing from one gender to another 
is called transitioning. Biological females who wish 
to live and be recognised as men are called female-
to-male (FTM) transsexuals or trans men. Biological 
males who wish to live and be recognised as women 
are called male-to-female (MTF) transsexuals or 
trans women. DSM-5 uses the term gender dysphoria 
instead of transsexual and this replaces the term 
gender identity disorder which was used in DSM-IV.
Disclosure: In Ireland the most common age at 
which LGBT people discover their LGBT identity is 
12, and the most common age at which they first 
disclose this to anyone is 17. This indicates that for 
most there is a five-year period where LGBT young 
people conceal their identity from family and friends 
and this period coincides with puberty, school and 
a critical period of social, emotional and vocational 
development in their lives.
Source: Gay and Lesbian Equality Network (2013) Lesbian, gay, 
bisexual and transgender service users: guidance for staff working 
in mental health services. Dublin: GLEN
Some key terms regarding LGBT  
service users
 
Sexual orientation refers to an enduring pattern of 
emotional, romantic and/or sexual attractions to 
men, women or both sexes. Sexual orientation also 
refers to a person’s sense of identity based on those 
attractions, related behaviours and membership in 
a community of others who share those attractions. 
Three sexual orientations are commonly recognised 
- heterosexual, homosexual (gay and lesbian) and 
bisexual.
Gender identity refers to whether one feels male or 
female regardless of sex assigned at birth. Gender 
expression refers to outwardly expressing one’s 
gender identity through mannerisms, grooming, 
physical characteristics, social interactions and 
speech.
Transgender is a term used to describe people 
whose gender identity or gender expression differs 
from the sex assigned to them at birth. Not everyone 
whose feelings, appearance or behaviour is gender-
atypical will identify as a transgender person. Many 
transgender people live full-time or part-time in 
their preferred gender.
Mental health and 
well-being of  
LGBTI people 
A report on the mental health and well-being of LGBTI 
(lesbian, gay, bisexual, transgender and intersex) people in 
Ireland was published on 22 March 2016.1 The largest study of 
LGBTI people in Ireland to date and the first to incorporate 
intersex people, the research was commissioned by the Gay 
and Lesbian Equality Network (GLEN) and BeLonG To, funded 
by the National Office for Suicide Prevention and undertaken 
by a team at Trinity College Dublin.
In the past 25 years Ireland has made great legislative 
strides in achieving equality for its LGBTI citizens. Despite 
this progress, there is little evidence of similar progress 
regarding general attitudes to LGBTI people among the 
wider Irish population. The aim of this study, undertaken 
just before the same-sex marriage referendum in May 2015, 
was to fill this knowledge gap. The study comprised two 
modules: (1) to gain insight into the lives of LGBTI people, in 
particular young people, by examining factors which affect 
their mental health and well-being; and (2) to assess public 
attitudes towards LGBTI people and how these can impact 
on LGBTI people. 
The selection criteria for inclusion in the first study module 
were any persons who lived in Ireland, identified as LGBTI, 
and over the age of 14. Participants were recruited mainly 
through social media, posters or by invitation through 
LGBT organisations. The vast majority completed the 
questionnaire online. 
Module 1 findings
In total, 2,264 people met the inclusion criteria and had 
provided sufficient information to be included in the study. 
Of these, 3.6% identified as gay males, 26.5% as lesbian/gay 
females, 14.4% as bisexual, 12.3% as transgender, 6.3% other 
identity2 and 2.0% as intersex. 
Nearly three-quarters (72%) of participants were aged 
between 14 and 35 years, with a mean age of 29.6 years 
(range 14-71 years). Younger people were overrepresented in 
the study, perhaps due to the nature of the recruitment of 
participants mostly through social media. The study included 
participants from all counties of the Republic with almost 
half (49.6%) of participants living in Dublin. Over 80% of 
participants were in paid employment or education. 
Self-esteem was gauged using the Rosenberg Self-Esteem 
Scale. Intersex, transgender and bisexual people had 
statistically significant lower self-esteem compared with 
gay males and lesbian/gay females. Younger age groups also 
had significantly lower self-esteem compared with their 
older counterparts. The life satisfaction and happiness 
of participants were also assessed, revealing that both 
improved with age. The mean scores for both satisfaction 
and happiness were lowest for transgender and intersex 
participants and highest for gay males. 
The majority of participants reported incidents of verbal 
abuse, while 20% reported physical attacks. Participants 
recommended stronger legal protection and increased 
visibility of LGBTI identities as a means of reducing exposure 
to these risks. The results also showed that many LGBTI 
people experienced mental health issues, mainly depression, 
anxiety and substance misuse. Almost 60% of the sample 
seriously considered suicide, and one in five had attempted 
suicide. The mean age of those who had attempted suicide 
was 18.5 years (range 6-55 years). 
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acceptable to discriminate against LGBTI people, 15% still 
believed using LGBTI slang words was not a major concern. 
This suggests that a section of society is unaware of the 
negative effects such slang can generate.
The public perception of what constitutes equal rights does 
not appear to match the views of the LGBTI community. One 
of the strongest findings from module 1 was the desire for 
normalisation and visibility of LGBTI relationships. However, 
the general population had noticeable levels of discomfort 
towards public displays of affection.
Recommendations
The report recommends seven strategies for achieving 
positive change for LGBTI: 
• Reduce mental health risks and build resilience among 
LGBTI people.
• Support the LGBTI community to flourish.
• Protect and support LGBTI children and young people in 
schools.
• Increase public understanding and change attitudes and 
behaviours.
• Recognise the diverse needs within the LGBTI 
community.
• Build the knowledge and skills of professionals and 
service providers.
• Conduct further research and assess progress.
Derek O’Neill 
1  Higgins A, Doyle L, Downes C, Murphy R, Sharek D, DeVries 
J, Begley T, McCann E, Sheerin F and Smyth S (2016) The 
LGBTIreland Report: national study of the mental health and 
wellbeing of lesbian, gay, bisexual, transgender and intersex 
people in Ireland. Dublin: Gay and Lesbian Equality Network 
(GLEN) and BeLonG To. http://www.drugsandalcohol.ie/25323/ 
2   Other identity: comprised participants who subscribed to 
another gender identity or sexual orientation outside of the LGBTI 
categories; see p. 39 of report.
3  Long J and Mongan D (2014) Alcohol consumption in Ireland 
2013: analysis of a national alcohol diary survey. Dublin: Health 
Research Board. http://www.drugsandalcohol.ie/22138/
4  National Advisory Committee on Drugs (2011) Drug use in 
Ireland and Northern Ireland: first results from the 2010/2011 
drug prevalence survey. Bulletin 1. Dublin: National Advisory 
Committee on Drugs and Public Health Information and Research 
Branch. http://www.drugsandalcohol.ie/16353/
Two-thirds of these people reported their suicide attempt(s) 
related to being LGBTI. 
The Alcohol Use Disorders Identification Test (AUDIT) was 
used to measure alcohol use, where depending on the score 
the participant fell into one of four categories. These are: 
no alcohol problems (≤7); medium level alcohol problems 
(8-15); high level alcohol problems (16-19); and very high level 
alcohol problems (>20). The mean score in this study was 8.1 
(range 1-33). Table 1 shows the mean audit scores by LGBTI 
group and age.
Table 1  Mean AUDIT scores by LGBTI group and age group
LGBTI group
L G B T I
M=7.32 M=9.02 M=7.49 M=7.46 M=7.09
(n=455) (n=710) (n=241) (n=185) (n=35)
Age group
14-18 
years
19-25 
years
26-35 
years
36-45 
years
46  
years +
M=7.14 M=9.18 M=8.57 M=7.41 M=6.38
(n=204) (n=486) (n=446) (n=290) (n=197)
 Source: Higgins et al. (2016)1
Almost half (43.8%) of the AUDIT scores in the sample 
indicated some level of alcohol problem or dependence. 
This is however approximately 10% less than previously 
indicated in a study involving the general population. Long 
and Mongan (2014) found that more than half (54%) of the 
general population of 18-75-year-olds are classified as 
harmful drinkers.3
Over half (55.9%) of the participants had taken recreational 
drugs. This is higher than the rate of 27% found in the 
general population.4 Almost 30% (29.8%) of 14-18-year-
olds had taken recreational drugs, while almost two-thirds 
(62.5%) of 19-25-year-olds had used recreational drugs. 
Cannabis, codeine-based drugs and MDMA/ecstasy were the 
three most commonly used drug types. 
Module 2 findings
In order to gauge societal attitudes to LGBTI people in 
module 2, some 1,008 telephone interviews with the general 
public were conducted. This part of the study found mixed 
views among the general population. For example, 75% of 
participants believed that LGB people’s sexual orientation 
was normal, 11% believed it was a phase that people would 
grow out of, while 17% believed that someone could be 
convinced to become LGB. A smaller proportion (56%) 
were uncomfortable with people who were transgender, 
perhaps due to a lack of understanding their identity. The 
general public were less comfortable with public displays 
of same-sex affection, e.g. 39% were uncomfortable with 
a male couple kissing in public compared with 17% for a 
heterosexual couple kissing in public.
Mental health and well-being  
of LGBTI people continued
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UPDATES
Recent 
publications
The following abstracts are cited from 
published journal articles recently 
added to the repository of the HRB 
National Drugs Library at www.
drugsandalcohol.ie  
Estimating risk of alcohol 
dependence using empirically 
validated ordinal risk zones versus 
recommended binary risk zones  
of the RAPS4: a validation study 
using stratum-specific likelihood 
ratio analysis
Cousins G, Mongan D, Barry J, Smyth B, 
Rackard M and Long J (2016) Alcoholism 
Clinical and Experimental Research 
40(8): 1700-1706
http://www.drugsandalcohol.ie/25734/
Effective treatment options for alcohol 
dependence exist; yet, only 10% of 
people with alcohol dependence 
receive treatment. The objective of 
the current study was to examine 
the performance of previously 
recommended Rapid Alcohol Problem 
Screen 4 (RAPS4) risk zones, based on 
single binary cut-points (RAPS4 ≥ 1; 
RAPS4 ≥ 2), and empirically identified 
RAPS4 risk zones to identify people 
with alcohol dependence so that 
further diagnostic assessment or 
interventions can be offered.
Stratum-specific likelihood ratio (SSLR) 
and receiver operating characteristic 
analyses were used to compare the 
screening performance of empirically 
identified ‘risk zones’ on the RAPS4 
to previously recommended binary 
cut-points in a general population 
sample of current drinkers in Ireland 
(N=4,267). SSLRs were also used along 
with the pretest prevalence of alcohol 
dependence to estimate posttest 
probabilities of alcohol dependence 
for the recommended and empirically 
identified risk zones.
The weighted prevalence estimate of 
alcohol dependence among current 
drinkers was 6.9% (9.3% men; 4.5% 
women). The SSLR analysis identified 
multiple risk zones in the RAPS4, with 
each of the individual scores (0, 1, 2, 3, 
4) retained as 5 separate ordinal risk 
zones for both men and women. 
A comparison of the area under the 
receiver operating characteristic 
curve showed that the ordinal RAPS4 
risk zones performed better than 
recommended binary thresholds for 
both men and women. Based on the 
pretest probability of 9.3% and the 
identified SSLRs for the ordinal risk 
zones, the posttest probability of 
alcohol dependence for men ranged 
from 1.6% for those in the lower risk 
zone (RAPS4 = 0) to 86.7% for those 
in the highest risk zone (RAPS4 = 4). 
The posttest probability of alcohol 
dependence for women ranged from 
0.4% for those in the lower risk zone to 
80% for those in the higher risk zone.
The detection of alcohol dependence 
may be improved using the empirically 
identified ordinal RAPS4 risk zones for 
both men and women. The application 
of the identified SSLRs, particularly 
if integrated into a clinical decision 
support system, may be helpful for 
clinicians in providing feedback to 
patients regarding their risk of alcohol 
dependence.
General Practitioner perspectives on 
and attitudes toward the methadone 
treatment programme in Ireland
Delargy I, O’Shea MT, Van Hout MC and 
Collins C (2016) Heroin Addiction and 
Related Clinical Problems 18(4): 43-50 
http://www.drugsandalcohol.ie/25746/ 
A report on this study is presented in 
this issue of Drugnet Ireland on page 18.
Parents who use drugs: the well-
being of parent and child dyads 
among people receiving harm 
reduction interventions for  
opiate use 
Comiskey C, Milnes J and Daly M  
(2016) Journal of Substance Use  
Early online.
http://www.drugsandalcohol.ie/25731/ 
This article provides baseline 
measurement of health outcomes for 
parent and child dyads among people 
receiving interventions for opiate 
use. A cohort study was implemented 
among 171 participants with 235 
children in three urban sites in Ireland 
in 2010/11. Adult and child outcomes 
were measured using the Short Form 
12, the Becks Depression and Anxiety 
Inventories, the Strength and Difficulties 
Questionnaire and the Kidscreen 27.
Over 60% of adult participants grew up 
in a household with at least one person 
who used substances. 
The main substance used was alcohol 
followed by heroin. A correlation 
was found between increasing adult 
anxiety and growing up in a home with 
a person using substances. Children of 
current parents had more difficulties 
with emotional and conduct problems, 
as compared to international norms. 
Correlations existed between current 
parental depression and anxiety and 
child conduct disorder. Parents who 
use drugs are part of the so-called 
‘sandwich generation’. Monitoring 
and evaluation of interventions that 
address outcomes across generations 
of parental and child dyads are lacking.
What is known about community 
pharmacy supply of naloxone?  
A scoping review
Nielsen S and Van Hout MC (2016)  
The International Journal of  
Drug Policy 32(1): 24-33
http://www.drugsandalcohol.ie/25729/
There is growing evidence that 
expanded supply of take-home 
naloxone to prevent opioid overdose 
deaths is needed. Potential routes for 
expansion of naloxone provision include 
through community pharmacies. 
The aim of this scoping review is 
to establish what is known about 
community pharmacy supply of 
naloxone, in light of unique challenges 
and opportunities present in 
pharmacy settings. A scoping review 
methodology was employed using the 
six stage iterative process advocated 
by Arksey and O’Malley (2005) and 
Levac et al. (2010). Searches used key 
words and terms such as ‘naloxone’; 
‘overdose prevention/drug overdose/
opiate overdose’; ‘community/retail 
pharmacy’; ‘pharmacist/pharmacy/
community pharmacy/pharmaceutical 
services’; ‘professional practice/
role’; ‘community care’; ‘attitude of 
health personnel’; ‘training/supply/
cost’. Appropriate search terms were 
selected for each database. After initial 
exploratory searches, comprehensive 
searches were conducted with 
Cochrane Database of Systematic 
Reviews, Medline, Medline in Process, 
Embase, PsycINFO and CINAHL. 
Eligibility criteria centered on whether 
studies broadly described supply of 
naloxone in community pharmacy or 
had content relating to community 
pharmacy supply. The search identified 
95 articles, of which 16 were related to 
pharmacy supply of naloxone. 
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after initial review of the data 
and consultation with the project 
Expert Group, and are: ‘Pharmacists 
Perceptions of Naloxone: Facilitators 
and Barriers’, ‘Patient Populations: 
Identification and Recruitment’, 
‘Supply Systems and Cost’, ‘Legal 
Issues’, and ‘Training of Pharmacists 
and Community Pharmacy Naloxone 
Recipients’. Findings from this scoping 
review suggest that the community 
pharmacy based route for distribution 
of take home naloxone provision 
warrants further consideration and 
development. Existing strengths 
include a range of established supply 
models, and training curricula, few 
direct concerns regarding legal 
liability of pharmacists in the supply of 
naloxone (once legal supply systems 
have been established) and the wide 
range of potential identifiable patient 
populations, which include pain 
patients that may not be in  
contact with existing naloxone  
supply programmes. 
How do we compare with best 
practice? A completed audit of 
benzodiazepine and z-hypnotic 
prescribing 
Rowntree R, Sweeney J, Crumlish N 
and Flynn G (2016) Irish Journal of 
Psychological Medicine
Early online.
http://www.drugsandalcohol.ie/25715/ 
The objective of this study was 
to compare benzodiazepine and 
z-hypnotic prescribing practices 
in an inpatient psychiatric unit to 
best practice standards. Medication 
charts of all inpatients in the 
psychiatric unit, over a 1-week period, 
were reviewed. Details of current 
benzodiazepine and z-hypnotic 
prescriptions were collected. 
Information collected included the 
substance prescribed, duration and 
administration instructions. Feedback 
was communicated to medical 
practitioners through a presentation 
and email. A re-audit was completed 4 
months later.
There were increases in total 
benzodiazepine and z-hypnotic 
prescribing despite intervention. A 
reduction of 2mg occurred in the 
mean regular dose of benzodiazepine 
prescribed. Lorazepam was the most 
prescribed benzodiazepine throughout. 
In both data sets, at least 50% of regular 
z-hypnotics and benzodiazepines were 
initiated before admission. 
There was an increase of 14% in 
regular benzodiazepines initiated 
in hospital exceeding 4 weeks in 
duration. In neither data collection 
did regular z-hypnotics initiated in 
hospital exceed this cut off. A greater 
number of individuals were in the 
process of being withdrawn from 
regular benzodiazepine or z-hypnotic 
prescriptions in the re-audit. There 
were minimal improvements in ‘as 
required’ prescribing as regards 
documentation of an indication, time 
limit and maximum dose.
The increase in overall prescribing, 
despite intervention, maybe because 
these medications continued to be 
indicated in the acute presentations 
needing inpatient treatment. The 
small improvements in ‘as required’ 
prescribing patterns suggest that the 
intervention was limited in effecting 
change in this area. 
Socioeconomic differentials in 
mortality by cause of death in the 
Republic of Ireland, 1984-2008
Layte R and Banks J (2016) European 
Journal of Public Health 26(3): 451-8
http://www.drugsandalcohol.ie/25660/
This paper provides an analysis 
of relative and absolute trends in 
mortality by cause of death and 
socioeconomic group (SEG) from 
1984 to 2008 among men and active 
women aged 30-64 years in Ireland and 
compares these results with recent 
European and US studies to give an 
overview of trends.
Mortality data from the Irish Central 
Statistics Office from 1984 to 2008 
were used to calculate standardized 
death rates by age, sex, socioeconomic 
status and cause of death showing 
trends in SEG inequalities in mortality 
in Ireland. These show which specific 
causes of death are driving all-cause 
mortality trends.
SEG differentials in all-cause mortality 
among men and women have been 
increasing since the 1980s. Some 
of this increase reflects larger falls 
in cardiovascular causes among 
advantaged groups, but the trend is 
largely accounted for by increasing 
inequalities in mortality in digestive, 
neoplasm and external causes of deaths.
These findings are in line with 
international findings that show 
that socioeconomic differentials in 
digestive, neoplasm and external 
cause deaths are driving general 
socioeconomic differentials in all-
cause mortality. External cause deaths 
may have been influenced by levels 
of economic activity, particularly in 
construction, during the economic 
boom among manual workers. 
Furthermore, deaths from digestive 
diseases during the 1990s and 2000s 
may well be the result of increases in 
liver disease associated with excessive 
alcohol consumption. 
‘Trip-sitting’ in the black hole:  
a netnographic study of dissociation 
and indigenous harm reduction 
Hearne E and Van Hout MC (2016) 
Journal of Psychoactive Drugs 
Early online. 
http://www.drugsandalcohol.ie/25845/ 
An array of dissociative novel 
psychoactive substances, including 
‘methoxetamine’, ‘3-MeO-PCP’, and 
‘methoxphenidine’, have emerged as 
substitutes for the illicit substance 
‘ketamine’. A netnographic research 
methodology aimed to describe 
online, dissociative novel psychoactive 
substance users’ perceptions of risk, 
informed knowledge around use, and 
indigenous harm-reduction practices 
as advocated within online drug fora, 
so as to provide credible information 
which can be used to inform public 
online health education and drug 
prevention. Systematic Internet 
searches were performed using 
the terms ‘synthetic dissociative’, 
‘methoxetamine’, ‘methoxphenidine’, 
‘diphenidine’, ‘3-MeO-PCP’, ‘4-MeO-
PCP’, ‘2-MDP’, and ‘dissociative 
research chemical’ in combination 
with ‘forum’. Following screening of 
3,476 forum threads with removal of 
duplicates and exclusion criteria, 90 
user trip reports and 115 fora threads 
from seven drug fora websites were 
analyzed by conducting content 
analysis. Five themes emerged with 
43 categories. The findings illustrated 
how forum activity within the cyber 
drug user community disseminated 
and exchanged ‘communal folk 
pharmacology’ relating to the use 
of dissociative novel psychoactive 
substances. Further research and 
consistent monitoring of Internet drug 
fora are advised to explore variations 
in harm-reduction tactics throughout 
dissociative NPS populations, and to 
consider how existing harm-reduction 
initiatives are influencing these hard-
to-reach groups.
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The changing landscape of Irish 
Traveller alcohol and drug use
Van Hout MC and Hearne E (2016)  
Drugs: Education, Prevention  
and Policy  
Early online. 
http://www.drugsandalcohol.ie/25843/ 
The aim of this commentary is to 
illustrate how the changing social 
situation and fragmentation of Traveller 
culture overtime which once offered 
resilience and protection against 
alcohol and drug abuse has contributed 
to a rise in associated problems and 
addiction within Traveller communities 
in Ireland. We present here extant 
available literature on this issue. 
Forensic analysis of P2P derived 
amphetamine synthesis impurities: 
identification and characterization 
of indene by-products 
Power JD et al. (2016) Drug Testing  
and Analysis 
Early online. 
http://www.drugsandalcohol.ie/25869/ 
1-Phenyl-2-propanone (P2P) is an 
internationally monitored precursor 
that has become increasingly difficult 
for illicit amphetamine producers to 
source, which means that alternative 
routes to its preparation have become 
increasingly important. One such 
approach includes the hydrolysis 
of alpha-phenylacetoacetonitrile 
(APAAN) with sulfuric acid. Previously, 
we reported the identification of 
4,6-dimethyl-3,5-diphenylpryid-2-one 
following implementation of hydrolysis 
conditions and it was proposed that 
this compound might serve as one 
route specific by-product in the APAAN 
to P2P conversion. 
This study continued to explore the 
presence of impurities formed during 
this conversion and expanded also 
into a second route of P2P synthesis 
starting from alpha-methylstyrene 
(AMS). All P2P products underwent 
the Leuckart procedure to probe 
the presence of P2P-related 
impurities that might have carried 
through to the final product. Two 
by-products associated with the 
APAAN hydrolysis route to P2P 
were identified as 2,3-diacetyl-
2,3-diphenylsuccinonitrile (1) and 
2-methyl-1-phenyl-1,3-dicarbonitrile-
1H-indene (2), respectively. Two 
by-products associated with the AMS 
route to P2P and subsequent Leuckart 
reaction were 1,1,3-trimethyl-3-
phenyl-2,3-dihydro-1H-indene (3) and 
1-phenyl-N-(phenylethyl)propan-2-
amine (4), respectively. 
The two indenes (2 and 3) identified in 
synthesized amphetamine originating 
from P2P suggested that it might be 
possible to differentiate between the 
two synthetic routes regarding the 
use of APAAN and AMS. Furthermore, 
the association of these compounds 
with amphetamine production appears 
to have been reported for the first 
time. The presence of compounds 1-4 
in seized amphetamine samples and 
waste products could facilitate the 
suggestion whether APAAN or AMS 
were employed in the synthesis route 
to the P2P. 
Buprenorphine-naloxone in the 
treatment of codeine dependence: 
a scoping review of clinical case 
presentations
Van Hout MC, Hearne E and Bergin M 
(2016) International Journal of Mental 
Health and Addiction 
Early online. 
http://www.drugsandalcohol.ie/25842/ 
Misuse of prescribed and over the 
counter (OTC) codeine containing 
medicines is an increasing public 
health concern in recent times. 
Studies have called for low threshold 
treatment services for individuals 
experiencing codeine dependence 
using buprenorphine naloxone therapy. 
We present a scoping review of clinical 
case presentation literature on the 
use of buprenorphine-naloxone in the 
treatment of codeine dependence. 
Seven records (four single case 
studies and three case series) on 
codeine dependence treated with 
buprenorphine-naloxone were 
included. Five themes emerged 
following a review of the cases for the 
treatment of codeine dependence 
with buprenorphine-naloxone. They 
are: (1) Patient Profiles; (2) History of 
Codeine Misuse; (3) Medical Problems; 
(4) Use of Other Substances; and 
(5) Buprenorphine-naloxone in the 
treatment of Codeine Dependence. 
The review highlights the complexities 
of patients with regards to pain, 
psychiatric illness, poly substance 
use and iatrogenic dependence, with 
findings encouraging in terms of patient 
stabilisation and recovery.
Test purchase, synthesis, 
and characterization of 
2-methoxydiphenidine (MXP) and 
differentiation from its meta- and 
para-substituted isomers
McLaughlin G et al. (2016) Drug Testing 
and Analysis 8(1): 98-109 
http://www.drugsandalcohol.ie/25870/ 
The structurally diverse nature of 
the 1,2-diphenylethylamine template 
provides access to a range of 
substances for drug discovery work 
but some have attracted attention 
as ‘research chemicals’. The most 
recent examples include diphenidine, 
i.e. 1-(1,2-diphenylethyl)piperidine 
and 2-methoxydiphenidine, i.e. 
1-[1-(2-methoxyphenyl)-2-phenylethyl]
piperidine (MXP, methoxyphenidine, 
2-MXP) that have been associated with 
uncompetitive N-methyl-D-aspartate 
(NMDA) receptor antagonist activity. 
Analytical challenges encountered 
during chemical analysis include 
the presence of positional isomers. 
Three powdered samples suspected 
to contain 2-MXP were obtained 
from three Internet retailers in the 
United Kingdom and subjected to 
analytical characterization by gas 
chromatography (GC) and high 
performance liquid chromatography 
(HPLC) coupled to various forms of 
mass spectrometry (MS). Nuclear 
magnetic resonance spectroscopy, 
infrared spectroscopy and thin layer 
chromatography were also employed. 
This was supported by the synthesis of 
all three isomers (2-, 3- and 4-MXP) 
by two different synthetic routes. The 
analytical data obtained for the three 
purchased samples were consistent 
with the synthesized 2-MXP standard 
and the differentiation between 
the isomers was possible. Distinct 
stability differences were observed 
for all three isomers during in-source 
collision-induced dissociation of the 
protonated molecule when employing 
detection under HPLC selected-
ion monitoring detection, which 
added to the ability to differentiate 
between them. Furthermore, the 
analysis of a 2-MXP tablet by matrix 
assisted inlet ionization Orbitrap mass 
spectrometry confirmed that it was 
possible to detect the protonated 
molecule of 2-MXP directly from the 
tablet surface following addition of 
3-nitrobenzonitrile as the matrix.
Recent publications continued
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16 A typology of alcohol consumption 
among young people: a narrative 
synthesis
Davoren MP et al. (2016)  
Addiction Research & Theory 
Early online. 
http://www.drugsandalcohol.ie/25207/ 
Currently, alcohol consumption 
levels are significantly higher among 
younger age groups. However, 
previous research has noted the 
diversity of motivations and patterns. 
These patterns of drinking have yet 
to be synthesised into a typology. 
The aim of the current study was to 
synthesise information from studies 
that produced types of alcohol 
consumption among young people.
Quantitative and qualitative literature 
investigating the different types of 
drinkers among young people [aged 
12-24 years], published in peer 
reviewed journals, were eligible for 
inclusion in this systematic review. 
MEDLINE, PsychInfo and CINAHL 
were systematically searched for 
relevant articles published between 
January 1st 2000 and December 31st 
2014. Included papers were critically 
appraised. A narrative synthesis 
approach was employed based on 
guidance from the UK Economic and 
Social Research Council.
In total, 13 studies were eligible 
for inclusion: 11 quantitative, one 
qualitative and one mixed methods. Six 
classes of drinkers were formed within 
this typology. Abstainers reported no 
alcohol consumption. Light drinkers 
reported drinking small amounts of 
alcohol infrequently. In comparison, 
social and hedonistic drinkers drank 
most in social situations and to have 
fun. Heavy and harmful consumers 
reported increased volume and 
frequency of consumption including 
harmful consequences.
Currently, policy makers are attempting 
to combat the high levels of harmful 
alcohol consumption among young 
people. The current typology provides 
guidance for targeted interventions in 
addition to a practical analytic tool in 
future research.
User experiences of development 
of dependence on the synthetic 
cannabinoids, 5f-AKB48 and 5F-
PB-22, and subsequent withdrawal 
syndromes
Van Hout MC and Hearne E (2016) 
International Journal of Mental Health  
and Addiction 
Early online. 
http://www.drugsandalcohol.ie/25835/ 
Emergence of synthetic cannabinoids 
(SCBs) in herbal smoking mixtures is 
a public health concern. New SCB’s 
such as 5f-AKB48 and 5F-PB-22 have 
been detected in French seizures 
and in sudden death post mortems 
in the US. The aim was to describe 
development of dependence on herbal 
smoking mixtures containing the 
SCB’s, 5f-AKB48 and 5F-PB-22 and 
subsequent withdrawal syndromes. 
Dependent users of herbal smoking 
mixtures known to contain the SCB’s 
5f-AKB48 and 5F-PB-22 with an 
average Severity of Dependence Score 
(SDS) of 13 were interviewed using a 
structured guide (three males/three 
females). Narratives were analysed 
using the Empirical Phenomenological 
Psychological (EPP) five step method. 
Six themes with 68 categories 
emerged from the analysis. Themes are 
illustrated as 1) Networks and Product 
Availability; 2) Drivers and Motives for 
Use; 3) Effect and Pathways toward 
Dependence; 4) Poly Substance Use 
and Comparisons to Natural Cannabis; 
5) Dependence and Withdrawal and 
6) Self-detoxification Attempts. Two 
higher levels of abstraction above 
these theme-levels emerged from the 
data, with sole use of herbal smoking 
mixtures containing 5f-AKB48 and 
5F-PB-22 centering on the interplay 
between intense cravings, compulsive 
all-consuming seeking, use and re-dose 
behaviours, and fear of the psychiatric 
and self-harms caused when in 
withdrawal. This is the first study 
describing dependence and withdrawal 
experiences in users dependent on 
5f-AKB48 and 5F-PB-22. Given the 
potential for adverse psychiatric and 
physical consequences of dependent 
use, further development of specific 
clinical responses and clinical research 
around toxicity and withdrawal severity 
are warranted.
Prevalence and risk factors for 
Hepatitis C viral infection amongst a 
cohort of Irish drug users attending 
a drug treatment centre for Agonist 
Opioid Treatment (AOT)
Keegan D, Crowley D, Laird E and  
Van Hout MC (2016) Heroin Addiction  
and Related Clinical Problems 
Early online. 
http://www.drugsandalcohol.ie/25815/ 
Injecting drug use (IDU) is a major 
driver of the European hepatitis C 
virus (HCV) epidemic. National data 
on prevalence of HCV amongst Irish 
drug users remains confined to certain 
treatment sites and prison settings. 
The aim of the study was to examine 
the prevalence of HCV infection and 
risk factors associated with infection 
among the 228 patients attending 
Opioid Substitution Treatment (OST) in 
a clinic in Dublin. 
A retrospective cross-sectional study 
was conducted using data collected 
from Health Research Board (HRB) 
forms and standardised written and 
electronic assessment forms routinely 
completed on OST initiation. The 
prevalence of HCV infection was 63.6% 
(n=145) with no significant gender 
difference (p=0.717). Patients who 
were infected with HCV were older 
than those uninfected (41.1 ± 7.5 years 
versus 37.5 ± 8.5 years; p=0.001), 
with prevalence significantly lower in 
younger adults (p=0.002). Multivariate 
analysis identified age of first drug use 
(p=0.002) and first injection (p=0.001), 
type of first drug used; cannabis 
(p=0.015), heroin (p=0.014) and cocaine 
(p=0.018) and early age of OST entry 
(p=0.001) as the most significant risk 
factors for HCV infection in this cohort. 
Those with no IDU had decreased odds 
of being HCV positive by 91.1%. Data 
for this Irish sample indicates high 
prevalence of HCV infection, and the 
need to consider age of first drug onset 
and injecting use, particular drug types 
and earlier commencement of OST to 
inform targeted HCV treatment and 
prevention interventions in Ireland.
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